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Breast cancer is the second most common cancer in the world and has the highest cancer 
mortality rate in women. Presently, 1 of every 4 women carry an increased risk of breast 
cancer, of which, 6% are below the minimum screening age of 45. Early detection via regular 
screening not only reduces mortality rates, but also decreases overall treatment expenditure. X-
ray mammography is the clinical standard breast cancer screening technique. However, due to 
significant limitations, such as unacceptable rates of false positive and false negative results, 
exposure to ionizing radiation, and discomfort and pain due to the compression of the breast it 
is not recommended for women under 45 years of age. These women also often have denser 
breast tissues, which further reduce mammography efficacy and diagnostic capability. 
 
Digital imaged elasto-tomography (DIET) has been developed to overcome some of the 
limitations of current techniques and mammography in particular. The digital imaged elasto-
tomography (DIET) concept is based on non-invasive, pain-free, vibration based analysis of 
local tissue stiffness, a form of elastographic reconstruction from actuation motion. This 
technique enables early detection of breast cancer, as it is not restricted in the ages of women 
who could utilize it for screening. Thus, combined with effective treatment, it could reduce 
mortality, particularly for younger women. More specifically, recent analysis showing annual 
mammography down to 40 years of age would save many more lives than current screening, 
indicating a system like DIET, safely offering screening to any age, could significantly improve 





DIET is a novel method and technology, but is not yet at a stage suitable for a large randomised 
clinical trial. However, its development could be significantly enhanced by a series of tools to 
improve the speed and repeatability of DIET technology development. Currently, DIET is 
developed primary by executing pilot clinical testing of human volunteers. This experimental 
approach is slow, not repeatable as technology progresses and thus not necessarily optima, as 
well as placing a burden on diagnosed volunteer patients. In particular, repeating trials is not 
possible, limiting the ability to accurately assess technological changes.  
 
The productivity of DIET technology development could thus be enhanced in three main areas: 
a) development of realistic and accurate tissue mimicking breast phantoms; b) validation of the 
surface measurement algorithms to quantify their error and thus to quantify the limits of 
diagnostic algorithms; and c) development of finite element models to accurately mimic breast 
phantoms to avoid repeated phantom experiments. The first would allow repeatable phantom 
trials in lieu of relying on volunteers. The second would enable more accurate assessment of 
errors and their impact on surface motion diagnostics. Equally, it would also allow assessment 
of whether improvements in sensing or actuation would make a clinical differences. The final, 
third element would further improve productivity by replacing phantom tests with models to 
generate “data”. The overall outcome is significantly enhanced development pathways. 
 
In this thesis, mechanical properties of three different materials; agar, gelatine, and silicone 
used to emulate the mechanical behavior of real breast tissue are measured to assess their 
suitability for use in phantoms in systems assessing tissue mechanics for diagnostics. The 
stiffness ratio of adipose to tumor between the phantom materials and real human tissues were 
compared. Hyperelastic parameters of Neo-Hookean, Mooney Rivil, and Ogden models were 




reliability, and repeatability. Finally, silicone based three homogenous phantoms of selected 
material were fabricated with different sizes of tumor. 
 
Finite element models of breast shaped phantoms were developed using ABAQUS software. 
The geometry of the model was constructed with the same dimensions from fabricated 
phantoms. The mechanical properties were modeled by using the Neo-Hookean hyperelastic 
material model. Results showed good to strong correlation ranging from 0.7 to 1.0 in all cases 
with over 90% having a value over 0.9.Overall, the comparison of the DIET experimental data 
and the FE model data showed good agreement. 
 
A single point laser Doppler vibrometer was used to validate the optical flow motion measuring 
algorithm used in DIET experimental data. Results show excellent validation with errors less 
than 6 % for healthy phantom, and errors less than 8 % for 10 mm and 20 mm inclusions. 
Overall results show the optical flow algorithm is validated with relatively small errors 
compared to a gold-standard, non-contact laser measurement. 
 
Finally, because of the validation effectiveness and accuracy of finite element modeling 
compared to DIET experimental data. Six new phantoms were modeled with different tumor 
positions. This analysis assess the impact of tumor position on diagnosis of breast cancer  using 
surface motions and basic elastography assumptions, which should further impact and 
encourage the development of DIET. 
 
Overall, all 3 goals are accomplished. The results of this thesis provide means to dramatically 
speed up development of the DIET system. More generally, they provide significant results to 












Breast cancer is a leading cause of death among women [1]. In 2012 almost 1.67 million new 
cases were diagnosed worldwide with approximately 324,000 and 198,000 deaths recorded in 
less and more developed regions, respectively [2]. Table 1 shows a summary of breast cancer 
worldwide in 2012 by the World Health Organization [3]. Regardless of advances in 
treatment over the past decades, breast cancer still remains the second leading cause of cancer 
related death in women [4].  The American Cancer Society estimated the number of new 
breast cancer cases and at 234,190, with around 40,730 deaths in the United States during 
2015 alone [5] . Of these deaths, 10,000 – 12, 000 cases are invasive cancer in women less 
than 40 years who are not typically screened [6], with around 3000 deaths in women aged 
less than 45 [7].  
 
Breast cancer is also the leading cause of cancer related deaths in New Zealand [8]. 
Approximately 3100 cases of breast cancer were registered in New Zealand in 2012, which is 
1 in every 1355 people in New Zealand [3]. Maori women are 28% more likely to be 
diagnosed with breast cancer, and 68% more likely to die from it, reflecting issues with 
genetics and compliance to screening [9]. The more common the cancer, the higher the 
results premature mortality rate.  
 
Breast cancer can affect both men and women of any age, but the incidence is much higher in 
women [10]. Several other factors increase the risk of developing breast cancer, including a 




hormone status, reproductive factors, and radiation exposure [11, 12]. The two most 
significant risk factors for women are family history and increasing age [13]. Thus, for 
example, risk of breast cancer increased for women of all ages in Hiroshima and Nagasaki 
due to low dose radiation exposure [12]. Nulliparity, early menarche, late menopause also 
increase womens‟ risk of developing breast cancer. Finally, during womens‟ reproductive 
years the ovary produces steroid hormones that directly affect development and function of 
the breast.[14, 15]. 
 
Table 1.1: Breast cancer worldwide in 2012 by World Health Organization [3] 
Regions Cases Deaths 5 year- prev 
Africa 99760 49061 317873 
United states of America 232714 43909 970693 
East Mediterranean 99284 42228 347565 
Europe 494076 142979 1936362 
South-East Asia 239612 109631 734902 
West Pacific 329762 85837 1276205 
China 187213 47984 697327 
India 144937 70218 396991 
 
Cancer treatments are expensive. In the United States breast cancer remains one of the most 
costly cancers [16]. In 2010, the United States spent approximately $16.5 billion on breast 
cancer treatment [17]. Reducing the cost of treatments and balancing patient needs with 
available healthcare resources is far from easy or intuitive. Using breast cancer related health 
insurance claims, Ray et al. [18] showed increased follow up periods for breast cancer 
patients were associated with reduced mean monthly per patient costs. However, the 
cumulative costs per patient increased from US$78,882 for a follow up period of <6 months 
to US$443,062 for a follow up period of >36 months, indicating timely treatment is cost 




mortality rate, but also decreases overall treatment expenditure [19, 20]. Thus, screening 
programs for the early detection of breast cancer are a key element for increasing the chances 
of successful treatment and reducing costs. 
 
There are several tests and examinations routinely used for the detection of breast cancer [21-
23]. To reduce breast cancer mortality rates, breast screening needs to be accurate [24], low 
cost, fast, and available without risk to women of all ages. However, such systems do not 
currently exist. 
 
The digital imaged elasto-tomography (DIET) concept is based on non-invasive, vibration 
based analysis of local tissue stiffness elastographic reconstruction [25-30]. The DIET system 
consists of 5 digital cameras and synchronized strobe lights to capture steady state surface 
motion in response to 16 – 50 Hz low amplitude sinusoidal mechanical actuation applied to 
the breast [31]. Several images are captured during one cycle of a given actuation frequency 
at different phases relative to the input motion [32-36]. Surface motions are used to assess 
local tissue stiffness for diagnosis of stiffer inclusions e.g. [27, 28]. Recent analysis showing 
annual mammography down to 40 years of age would save many more lives than current 
screening [37], indicates a system like DIET, safely offering screening to any age could 
improve breast cancer mortality. 
 
 
1.1 Basic overall anatomy of the breast 
The healthy breast contains glandular, fatty, and fibrous tissues located over the pectoral 
muscles of the chest wall and connected to the chest wall by fibrous strands. Figure 1.1 shows 





The glandular tissue includes both ducts and lobules.  Each female breast is structured into 15 – 
20 lobe sections. Each lobe consists of many smaller lobules, where milk is produced, which 
connect through a tiny tubes called ducts that lead out to the nipple [38]. 
 
Fatty tissue also known as adipose tissue gives the breast shape and size. The majority of the 
breast contains adipose tissue. Three kinds of fats can be found in the woman breast. The fat 
that can be found directly under the skin is called subcutaneous fat. The fat that can be found 
surrounded by the lobes is called mammary layer. The fat found at the back of the breast, 
above the pectoral muscle layer, is called retro-mammary fat. Behind the retro-mammary fat 
are two major muscles, called pectoralis major and pectoralis minor which lies underneath the 
breast tissue. 
 
Most breast cancers form initially in the ducts of the breast [39]. The stages of cancer range 
from stage 0 to stage IV. Stage 0: carcinoma in situ (also known as pre-cancerous); Stage I: 
smaller tumor approximately 2 cm with no lymph node involvement; Stage II: tumor size 
approximately 2-5 cm with/without nodal involvement; Stage III: tumor that has invaded the 
chest wall without metastasis; Stage IV: any size of tumor and nodal involvement as well as 
distant metastasis [40]. Earlier detection is generally at stage 0 to II, although aggressive 
cancers can advance rapidly in the interim between early screening tests. 
 
 
1.2 Stage-0 breast cancer 
Stage-0 are a non-invasive cancers. The two most common types of pre-cancers are Ductal 




within the milk ducts, where LCIS is a condition in which abnormal cells are found in the 
lobules of the breast, as shown in Figure 1.1. As noted, most breast cancers initially form in 
the ducts of the breast. 
 
 
Figure 1.1: DCIS and LCIS abnormal cells [41] 
 
DCIS and LCIS may increase the risk of developing invasive cancer, which is the next stage. 
When the disease is confined to the ducts it is called “intraductal cancer”. These types of 
cancers do not have the potential of spreading and are curable. Some carcinoma in situ 
lesions are believed to rapidly transit to invasive, while others remain unchanged [42]. 




likely to progress to invasive breast cancer, but up to 40% of lesions progress to invasive if 
untreated [43]. 
 
When the cancer cells break out of the duct, the cancer becomes an “infiltrating ductal 
carcinoma”. At this time, the cancer cells may gain access to the lymphatic spaces and blood 
vessels in the breast. In the last stage of breast cancer IV, distant or metastatic cancer, it has 
spread to distant organs, such as the brain, lung, or liver [44]. 
 
 
1.3 Significance of this research 
Among women, breast cancer is the most common type of cancer. Millions of women 
diagnosed with breast cancer and many of them die every year worldwide. It is the second 
leading cause of cancer deaths in women. Research has shown early detection, combined 
with effective treatment, can reduce mortality [23].  
 
A number of screening tests have been employed, but these methods have limitations, such as 
unacceptable rates of false positive and false negative results, contribute to harm, and have 
limitations in age due to exposure to ionizing radiation. They also require qualified 
radiologists, and/or expensive technicians and equipment, which raises cost. Thus, there is a 
need for a better screening method. The work of this PhD aims to contribute to the 
development of a novel method for breast cancer screening using surface motion tracking of 
the skin. These motions can be used to infer the composition of the internal structure of the 
breast, where stiffer cancerous tissues have significant contrast to surrounding healthy 





Digital imaged elasto-tomography (DIET) is a low cost, radiation-free, non-invasive breast 
cancer screening technique. It analyses local tissue stiffness based on elastographic 
reconstruction and/or estimation of underlying tissue stiffness [23, 25-28]. In particular, 
DIET captures steady state surface motion in response to 16 – 50 Hz low amplitude 
sinusoidal mechanical actuation applied to the breast [31], and can use a range of methods to 
identify regions of high underlying stiffness, leveraging the high contrast between healthy 
and cancerous tissues [28]. 
 
DIET technology is not yet suitable for a large randomized clinical trial. In particular, there 
are issues concerning its speed of development that could be addressed by a series of tools to 
enhance the speed and repeatability of DIET technology development. Currently, DIET is 
developed largely based on clinical testing of human volunteers in pilot clinical trials, leading 
to a build and test approach, which is slow and not necessarily optimal as many volunteers 
have been recently diagnosed with cancer and thus their tests cannot be repeated when 
technology improves. 
 
Three main areas where this productivity could be enhanced include: a) development of 
realistic, accurate tissue mimicking breast phantoms; b) validation of the surface 
measurement algorithms to quantify their error and thus to quantify the limits of diagnostic 
algorithms; and c) development of finite element models to accurately mimic breast 
phantoms to avoid repeated phantom experiments. Such a set of tools would allow much 
more rapid and optimal development of diagnostic metrics, as well as for developing 
optimised surface motion measurement algorithms. They would allow finite element models 
to generate data the same as that for realistic phantoms, allowing a rapid test cycle of many 




phantoms could be run to validate these results or optimize them further. Finally, when ready, 
clinical testing on human volunteers could be undertaken with far greater confidence of 
success.  
 
This thesis thus addresses these three areas. It develops tools for each of them, and validates 
the current optical flow algorithm used to obtain surface motion measurements [46]. Together 




The thesis is organized as follows: 
 
Chapter 2: Background and literature review. This chapter provides an overview of the 
working principles, benefits, limitations, performance, and cost of current breast cancer 
detection techniques. It is based on an extensive literature review focusing on published 
works reporting the main performance, cost, and comfort/compliance metrics considered. 
Due to limitations and drawbacks of existing breast cancer screening methods there is a need 
for better screening methods. Emerging, non-invasive methods offer promise to mitigate the 
issues particularly around comfort/pain and radiation dose, which would improve compliance 
and enable all ages to be screened regularly. 
 
Chapter 3: Mechanical behavior of tissue mimicking breast phantom materials. In this 
chapter, the mechanical properties of three different materials used to emulate the mechanical 
behavior of real breast tissue are measured: agar, gelatin, and silicone, to assess their 




Chapter 4: Finite element modelling of breast shaped phantom. In this chapter, three different 
phantoms were modelled: healthy, with 10 mm and 20 mm inclusions. The overall goal is to 
create models with enough accuracy to replace experimental phantoms in providing data to 
optimize diagnostic algorithms for digital imaged elasto-tomography (DIET) screening 
technologies. 
 
Chapter 5: Validation of finite element modelling with DIET experimental data of breast 
shaped phantom. In this chapter, validation of FE model results with experimental DIET 
phantom data uses cross correlation coefficients between experimental simulated data, and 
direct comparison for over 4000 collected points on each model and phantom. 
 
Chapter 6: Laser Doppler vibrometer validation of an optical flow motion tracking algorithm. 
The focus of this chapter is to validate recorded peak of horizontal displacement of DIET 
experimental data and laser Doppler vibrometer data at frequencies of 16Hz, 24Hz, 32Hz, 
and 40Hz on the breast shaped phantom with and without 10 mm and 20 mm stiffer 
inclusions.  
 
Chapter 7: Finite element modelling for different sizes of inclusion at different positions. In 
this chapter the same modelling procedure were followed from chapter 4 and 5. Total 6 
phantoms were modelled with 10 mm and 20 mm at three different positions at frequencies of 
16 Hz, 24 Hz, 32 Hz, and 40 Hz. 
 
Chapter 8: Conclusions. This chapter concludes the research results and main content of this 
thesis. 









Early detection of breast cancer, combined with effective treatment, can reduce mortality. 
Millions of women are diagnosed with breast cancer and many die every year globally. 
Numerous early detection screening tests have been tested and employed. A wide range of 
current breast cancer screening methods are reviewed based on a series of searches focused 
on clinical testing and performance. The key factors evaluated centre around the trade-offs 
between accuracy (sensitivity and specificity), operator dependence of results, invasiveness, 
comfort, time required, and cost.  All of these factors affect the quality of the screen, 
access/eligibility, and/or compliance to screening programs by eligible women.  
 
This chapter thus provides an overview of current breast cancer detection techniques in light 
of cost, invasiveness and comfort/compliance metrics. All these issue play a role in the 
quality and compliance of screening, and thus efficacy of screening programs. Finally, it thus 
sets the context and stage for the research in this thesis. 
 
 
2.1 Current methods of screening for breast cancer 
2.1.1 Mammography 
Over the years, X-ray mammography (XM) has become the primary, non-self-exam 
screening technique for breast cancer [7, 45]. Mammography forms images of breast density 




ionising radiation may be harmful and possibly cause cancer itself [46]. Risk is one of the 
reasons it is not recommended for screening in women under a minimum of 40 years [47], 
and is typically reserved for women over 45-50 years. 
 
Mammography can provide benefit to women aged 40 to 49 years. Mortality rates at these 
ages can be reduced up to 15% after 14 years of follow up [48]. However, women who 
started screening every second year at age 50, until 69 years of age, have shown more benefit 
with less harm [49, 50], and thus this age range and interval are more commonly used in 
national screening programs. Due to the extensive validation and use, mammography is the 
most widely used and well-accepted imaging modality for breast screening [51]. 
 
However, mammography has also been criticized for a number of reasons. Thornton and 
colleagues listed physical, emotional, social, financial, and/or psychological harm caused by 
mammograms [52]. Additionally, to get the best possible images, the breast tissue must be 
squeezed between two plates as the image is taken [53]. Many women found this 
compression painful and uncomfortable [54]. Several women experienced enough pain that it 
affected their decision to attend another examination [55-59], reducing compliance and thus 






Figure 2.1: (a) Mammogram Equipment (National Cancer Institute by Alan Hoofring, 2003), 
(b) Mammogram showing a small cancerous lesion as well as calcific deposits in veins 
(National Cancer Institute, March 1991) 
 
Mammographic breast density is a strong predictor of breast cancer [60-63]. However, denser 
tissue is harder to compress, reducing image quality and detection potential. Younger women 
naturally have denser breast tissue and it can be difficult to detect cancer with mammography 
[64]. All of these issues can lead to misdiagnosis and increased false positive/negative rates 
[65].  
 
Mammography with adjunctive ultrasonography results in higher rates of cancer detection in 
younger women or those with dense breast tissues, but also increases the number of false 
positive results [66]. The Japan Strategic Anti-cancer Randomized Trial (J-START) 
investigated sensitivity and specificity with 36,000 women in each group (XM and XM+US) 




specificity drops to 87%. Thus, positive predictive value is likely poor given low incidence 
rates [67]. 
Mammography is highly dependent on equipment, operator, radiologist, and breast density. 
False-negative rates for mammography range from 4% to 34% [68-72]. Table 2.1 provides a 
summary of published performance results for mammography. Research has shown that the 
sensitivity of mammography for detecting multiple malignant foci is often less than 50% [46, 
73, 74]. Due to radiation exposure and false positive results, both patients and physicians are 
concerned about using mammography to screen women under 45 years [75]. These 
limitations have this caused many unnecessary biopsies due to the low specificity of 
mammography [76].  
 
Finally, and more positively, mammography has been proven and established in terms of its 
detection of ductal carcinoma in situ (DCIS) [77]. It is also established in terms of potentially 
differentiating the micro-calcifications that can occur in breast tissue from cancerous lesions. 
However, as noted, these difficult cases are also a function of operator and radiologist 
experience and capability, even though the physics of the modality enables their detection, 
differentiation and diagnosis. 
 
The financial costs of breast cancer are high. Several studies show breast cancer screening for 
women aged 50-70 years is cost-effective and costs range between $13,200 and $28,000 per 
year of life saved [78-82]. In New Zealand, a mammogram costs approximately $180 [83]. 
However, for women below 45 years the number of false positives and cost for extra 
examinations, unnecessary biopsies, and other effects, means it is not cost effective [84-86]. 




imaging modalities for breast cancer screening and diagnosis, particularly those suited to 
younger women or those with dense breast tissue, with reduced total costs a further goal. 
 
Mammography usually takes only one picture, across the entire breast, in each of two 
directions: top to bottom and side to side. Digital breast tomosynthesis is a technique that 
creates a 3-dimensional picture of the breast to improve breast cancer detection especially 
with dense breast [87, 88]. Digital breast tomosynthesis has improved on the limitations of 
traditional digital mammography by increasing cancer detection and decreasing false-positive 
examinations [89]. Additionally, a digital breast tomosynthesis can reduce the pain and 
discomfort arising from compressing breast between two plates while performing a 
mammogram. For these reasons digital breast tomosynthesis can replace traditional 
mammogram in breast cancer screening [90]. The major disadvantage of digital breast 
tomosynthesis is prolonged time and more radiation exposure at twice that of standard 
mammography. Even though it reduces the need for repeat mammographic images and the 
increased dose from those tests, this added radiation is seen as excessive. In addition, it leads 
to increased recommendations for biopsies, increasing detection, but also cost when cancer is 
not present due to increased false positives [91]. 
 
Overall, it is still important to note that mammography is still the only proven and accepted 
wide scale screening modality. 
 
2.1.2 Magnetic Resonance Imaging  
Magnetic resonance imaging (MRI) has been progressively integrated into breast imaging 
and is used to detect lesions [92]. A magnetic field is created to align all the protons in the 




the protons realign, they emit radio waves which used to determine the molecule type and 
location. These radio signals are analysed and converted into an image [93]. When applied to 
soft tissue, MRI can be used to generate highly detailed images of the internal structure of the 
breast. MRI signal strength, and thus image contrast, is determined by the density of 
hydrogen protons within the imaged tissue and their response to rapidly changing radio 
waves and magnetic fields. The image contrast of MRI systems can be significantly enhanced 




Figure 2.2: (a) MRI Equipment, (b) MRI of individual breast, demonstrating marked 
enhancement (bright area) which was confirmed to be cancer (National Cancer Institute, 
February 1994) 
 
MRI can provide superior imaging results and outcomes compared to mammography and 
other breast screening techniques for women at high risk of breast cancer [95, 96]. MRI is a 
sophisticated imaging method without the need for ionizing radiation and therefore does not 




and for this cohort annual MRI is recommended first for screening with further validation of 
the outcome [98]. 
 
However, there are many unresolved issues in using MRI for breast cancer screening, 
including lack of standardised techniques and interpretation criteria [99]. In 2013, Sutcliffe Iii 
and his colleague published an article which reiterated the issues with MRI and noted that the 
different levels of training and experience of the radiologist result in significant variation in 
MRI findings of benign and malignant tumours [100]. Other limitations mentioned in past 
studies have also suggested MRI is less reliable in the detection of ductal carcinoma in situ 
(DCIS) because it is unable to image calcifications, tiny calcium deposits that can indicate 
breast cancer [14]. 
 
The U.S. Food and Drug Administration (FDA) approved MRI in 1991 to help diagnose 
breast cancer. However, because of its high sensitivity and lower specificity which can lead 
to false positives, the American Cancer Society does not recommend MRI for all women 
[101, 102]. The range of specificity varies from 37% to 100% [103-107] and this low 
specificity leads to more false positives and unnecessary biopsies [108]. These outcomes are 
summarised in Table 2.1. 
 
To improve specificity, recommendations for breast MRI state dynamic contrast enhanced 
(DCE) acquisition should be obtained [109]. The most widely used form of DCE-MRI 
analysis is the assessment of the type of time-signal intensity curve. The shape of the time-
signal intensity curve is an important criterion in differentiating benign and malignant 
enhancing lesions [110]. To further improve lesion classification, a high-resolution T2 




[109, 111, 112]. However, these changes make breast MRI time-consuming, with report 
investigation times between 20 and 40 min [113], and significantly increase cost, as well. 
 
More specifically, the cost of MRI is approximately ten times the cost of mammography [47]. 
Since the current cost of mammography is one factor leading to limited mammogram 
prescription and use, this added cost is not sustainable for wide scale screening. MRI cost 
with screening and treatment is estimated at $123 672 per detected breast cancer [114], which 
is ten times higher than mammography. In addition to the high cost, results take more time to 
produce [115, 116], and there is a lack of standardization in terms of technique, as well as 
interpretation guidelines [100]. Thus, its screening use is limited and relatively very costly. 
 
2.1.3 Ultrasound  
Ultrasound sends high frequency sound energy into the tissue from a hand-held transducer. 
This sound is reflected by boundaries between tissue where the acoustic impedance changes. 
Reflected sound is received by the transducer and the depth of reflection can be determined 
by „time of flight‟. Depth and detection information is combined into an image of cancerous 
tissue, as it has different density to surroundings tissue. This modality is illustrated in Figure 
2.3. 
 
Ultrasound is currently used to differentiate breast masses [117], and guide aspirations and 
biopsies [118]. Studies report ultrasound as a useful adjunct to mammography, and that in 
this role it yields improved cancer detection [119-121]. However, it is not recommended as a 
screening tool, in part because it is more specifically useful in clinical use for assessing 





Current technological advances in ultrasound equipment include very high-frequency 15MHz 
and multi-array transducers, as well as matrix broadband transducers. These transducers 
provide high levels of spatial and contrast resolution theoretically allowing detection of breast 
carcinomas as small as a few millimetres. To yield the highest spatial resolution, all modern 
transducers should be operated at the highest clinically appropriate frequency. However, high 
resolution ultrasound equipment can be much more expensive that traditional machines. In 
addition, there is a limitation that no high frequency probe can image deeper than 4 cm and 
this limitation should be kept in mind when evaluating large breasts or deeper situated 
lesions, as the operator may have to switch to a lower-frequency probe to achieve better 
penetration and a wider field of view with concomitant loss of resolution [123]. 
 
 
Figure 2.3: (a) US Equipment, (b) Ultrasound elastography of ductal invasive carcinoma in a 
51 year old patient with blue elastic appearance and desmoplastic reaction [51] 
 
Similar to Mammography and MRI, ultrasound also has limitations. It too requires a well-
trained, skilled operator and a follow up team that includes radiologists, breast surgeons, 
pathologists, and expert physician input to interpret images [124]. Screening takes 15min or 




images manually. Each of these aspects introduces subjectivity and error based on 
experience, as well as added cost. 
 
Costs for ultrasound screening include review by radiologists, technician time, and 
communicating results to the doctors. The average cost per patient has been estimated at €127 
(US $ 115) [125], but may vary by country. Hence, it is almost similar to mammography in 
cost, but with other limitations. 
 
Even at high frequencies, ultrasound has relatively low spatial resolution, low specificity 
[126], and is unable to image micro calcifications [127], especially when they are inside 
fibroglandular breast tissues [128-130]. These factors all increase the rate of false positive 
and false negative results [131, 132]. Table 2.1 summarizes the reported performance of 
ultrasound in breast cancer screening. The performance, particularly the percentages range of 
false positive rate (FPR) and false negative rate (FNR) are higher than for other modalities, 
limiting its efficacy in widespread screening or pre-screening, and increasing its cost per 
cancer detected. 
 
2.1.4 Thermography  
Thermography (TG) was one of the earliest breast cancer screening techniques to be 
developed [133]. Lawson published the first breast thermogram in 1957 [134-136]. 
Thermography is a non-contact imaging technique widely used in biomedical research [137-
139], including breast cancer detection [127, 140]. The modality is illustrated in Figure 2.4. 
 
Anybody with a temperature above absolute zero emits infrared radiation, where the wave 




radiation from the skin, and is completely non-invasive and non-contact [142]. Temperatures 
of the skin over a tumour are reported to be significantly higher than normal skin temperature 
due to increased blood flow [133]. The particular temperature and humidity for thermal 
images used in this application are thus critical and range from 20 to 25 
o
C and 40 to 60%, 
respectively [143]. Unlike mammography, there is no radiation risk in thermography and it is 
thus suitable for screening at any age [144]. 
 
However, this technique also has no standard examination procedure [145, 146], and is very 
environment dependant [147, 148]. Thus, before a test it is recommended that patients should 
rest for at least 15min to reduce basal metabolic rate and temperature changes [149].  Another 
difficulty of thermography screening is to localise the exact tumour position. All of these 
factors lead to a high level of variability in test quality and efficacy, as well as increased 
sensitivity to operator skill and experience [150]. 
 
The performance of thermography, as reported by several authors, is summarised in Table 
2.1.  A high rate of false positives limits thermography as a screening tool for breast cancer. 
Studies show that most false negative results were microcalcifications, meaning that this 
screening tool is unreliable for detecting these abnormalities [151]. In addition, the cost of 







Figure 2.4: Thermography equipment which shows body temperature 
 
Overall, the method was dismissed in the late 1970‟s due to a very high percentage of false 
detections resulting from inadequate imaging procedures and the lack of high resolution 
thermal imaging equipment at the time. In addition, after 1977, researchers found other 
screening modalities provided better results than thermography. Therefore, the medical 
community lost interest in this modality [152]. 
 
2.1.5 Microwave Imaging 
Microwave imaging (MI) is based on the dielectric properties of tissues. This imaging 
technique is applicable to breast cancer detection, due to the differences in dielectric 
properties between normal and malignant breast tissues [153-156]. There are three types of 





Passive microwave relies on tumour temperature and detects regions of increased temperature 
in the breast [157-159]. The key concept of passive microwave imaging is similar to 
thermography with a different spectrum range [160]. Hybrid microwave imaging methods 
heat tumours with microwaves and form images using an ultrasound transducer to detect 
pressure waves generated by the expansion of heated tissues [161]. Active microwave 
imaging techniques are classified as radar or tomographic methods. In both active and passive 
approaches, scattered microwave signals are measured after transmitting low-power 
microwave signals into the breast using an array of 16 antennas attached in a circular fashion. 
Each antenna in turn transmits electromagnetic waves in the microwave spectrum and the 
remaining 15 antennas collect measured data [156, 162]. 
 
In the tomographic approach, narrowband signals are used to record a set of scattering 
parameters for the breast. An inversion algorithm is used to reconstruct a complete map of the 
dielectric properties of the breast [163, 164]. In contrast, radar methods use wideband or 
ultra-wide band (UWB) signals to create images indicating the presence and location of 
significant scattering objects [165]. 
 
Active microwave imaging techniques are totally dependent on the dielectric properties: 
permittivity and conductivity. It is reported that dielectric properties for cancerous tissues are 
three or more times greater than healthy tissues providing potentially goal contrast for 
detection [166]. Radar-based approaches have only involved testing with phantoms [167, 
168] and early-stage clinical investigations [169]. There are thus few reports on clinical trials 
that reflect the significant technical challenges involved in sensor design and implementation, 





Unlike mammography, this technique is free from ionizing radiation, non-invasive, requires 
no breast compression, and is less expensive than MRI [170]. The major hurdles limiting 
patient use are both at the hardware level due to challenges in collecting accurate and no 
corrupted data, and software level, where they are often plagued by unrealistic reconstruction 
times in the tens of hours. Resolution of the image is also limited to 0.5cm and 1.0 cm in 
healthy and denser breast, respectively, which limits overall and early detection [156]. Hence, 
these modalities are not yet ready for application. 
 
2.1.6 Elastography 
Elastography (E) is a medical imaging technique to examine elastic properties of breast 
tissues, and this technique may be useful to distinguish malignant and benign masses [171]. 
In elastography, static and dynamic are two methods to examine mechanical properties [172, 
173]. Based on viscoelastic behaviour of breast tissues, echo signals are obtained before and 
after compression from tissues and then converted to displacement distribution images. From 
measured displacement, elastography is able to provide tissue stiffness information [174]. 
 
Elastography is currently the most widely method used in clinic. In various organs, such as 
the breast, prostate, and thyroid, elastography has proven highly accurate in the evaluation of 
cancerous tissues [175, 176]. Ultra-sonographic (US) elastography was introduced to 
overcome limitations of ultrasound and mammography alone, where it combines US 
technology and the basic principles of elastography [177, 178].  
 
The combination of ultrasound elastography and sonography had the best results in detecting 
cancer with an average 89.7% sensitivity and 95.7% specificity. Due to the lowest false-




unnecessary breast biopsies [179]. The performance of elastography reported by several 
authors is summarised in Table 2.1.  
 
Elastography potentially is lower cost than MRI [180]. Some lesions may contain benign and 
malignant, elastography can be helpful working with complicated breast lesions. 
Additionally, elastography reduces unnecessary biopsies costs [181]. However, elastography 
is expensive, time consuming, and error prone reconstruction inverse problems is a major 
issue preventing its wider use [26, 182]. 
 
2.1.6.1 Digital Imaged Elasto-Tomography 
The fundamental concept of DIET (digital imaged elasto tomography) is based on 
elastography and was first published in 2004 [25]. DIET is non-invasive, portable, 
inexpensive, comfortable breast cancer screening technique that measures the stiffness of 
tissue within the breast [27, 30, 36]. Its goal is to maximize the advantage of elastography, 
while removing its limitations. 
 
The DIET system consists of 5 digital cameras and synchronised strobe lights that capture 
low amplitude surface oscillations in the range 16 – 50 Hz generated by mechanical actuation 
applied to the breast [36]. The DIET approach consists of the steps summarised in Figure 2.5. 
Several images are captured during one cycle of a typical frequency, all at different phase 
angles relative to the input motion, as shown in Figure 2.6. To avoid the need for expensive 
high frame rate cameras and to reduce the impact of motion on image quality, a strobe 
lighting system is used in conjunction with the cameras [35, 183]. Areas of higher stiffness 





Figure 2.5: Concept of DIET 
 
To reconstruct skin surface motion, an optical flow algorithm is applied to pairs of frames. A 
3D model of the breast surface is also computed and combined with the optical flow data to 
give the 3D motion of the surface of the breast [36]. The motion is then analysed in a variety 
of objective algorithm based ways to detect stiffness differences and tumours [27, 28, 184]. 
 
A silicone-based hydrogel phantom was used during developmental testing of DIET because 
of its linear elastic behaviour and similar mechanical properties to human soft tissue [184, 
185]. During concept validation, DIET produced encouraging results [26, 32, 34, 186-188]. 






Figure 2.6: A schematic detail of timing of the image capture process 
 
The main features are non-invasive, low cost, and fast. Phantom studies have shown the 
method is capable of detecting stiff inclusions that mimic cancer. Therefore, it could prove 
suitable for screening at any age. In addition, it is portable and requires no specialist user, 
reducing variability. All these factors, and its reliance on low cost digital imaging sensors, 




Tables 2.1 and 2.2 and Figure 2.7 provide an overview of all modalities concerning 
advantages and disadvantages, such as economic, speed, accuracy, operator independency, 




modality interacts in terms of the key features considered. The results summarised here, 
particularly in Table 2.1 and Table 2.2, clearly show the advantages of the current standard, 
mammography, in performance, but also its disadvantages in regards to its invasive nature, as 
well as its wide variability in diagnostic performance. Equally, the results show the potential 
of emerging modalities, such as ultrasound and elastography, assuming they can overcome 
specific limitations they face in performance and/or lack of significant clinical data and 
testing.  
 











(#Pos / #Neg) 
Mammography 
Kuhl et al. 
[189] 
 
33.0 67.0  93.0 7.0 (9 / 96) 
Dodd [190] 87.2 12.8  85.1 14.9 (3661 / 4051) 
Kolb et al. 
[191]  
 
77.6 22.4  98.8 1.2 (246 / 27579) 
Manoliu and 
Ooms [192] 
86.6 13.4  80.7 19.3 (279 / 376) 
Ohlinger et al. 
[193]  
100.0 0.0  72.7 27.3 (3 / 11) 
Habib et al. 
[194] 







91.8 8.2  95.6 4.4 NA 
Luczyńska et 
al. [196] 
91.0 9.0  15.0 85.0 (114 / 59) 
Burman et al. 
[66]  
97.8 2.2  83.9 16.1 (47 / 5059) 
Egan and  
Egan [197] 
77.4 22.6  67.4 32.6 (31 / 46) 
MRI 




70.4 29.6 (36 / 108) 












95.0 5.0 (9 / 96) 




73.3 26.7 (25 / 15) 




90.3 9.7 (98 / 166) 




100.0 0.0 (41 / 4) 
Ultrasound 
Kolb et al. 
[191]  
75.3 24.7  96.8 3.2 (146 / 13,401) 
Egan and Egan 
[197]  
67.7 32.3  93.5 6.5 (31 / 46) 
Satake et al. 
[202] 
89.6 10.4  76.5 23.5 (29 / 17) 
Lumachi et al. 
[203] 
67.5 32.5  80.0 20.0 (37 / 40) 
Stavros et al. 
[204] 
98.4 1.6  67.8 32.2 (125 / 625) 









(3 / 11) 
 
Kuhl et al. 
[189] 
33.0 67.0  80.0 20.0 (9 / 96) 
Habib et al. 
[194] 
94.4 5.6  70.0 30.0 (18 / 10) 
Chang et al. 
[205] 
95.5 4.5  91.4 8.6 (110 / 140) 
Chang et al. 
[206] 
95.5 4.5  77.8 22.2 (110 / 140) 
Thermography 









88.0 12.0 (22 / 25) 




68.8 31.2 (66 / 144) 




84.9 15.1 (20 / 106) 















89 79 NA 
Thomas [175] 82 18  87 13 (300 / 0) 
Evans [176] 97 3  83 17 (53 / 0) 
TPR = True Positive Rate (Sensitivity), TNR = True Negative Rate (Specificity), FNR= False 






Table 2.2: All modalities in terms of main aspects 






Elastography       
X-ray 
Mammography 
      
MRI       
Ultrasound       
Microwave 
Imaging 
      
 
 
Figure 2.7: All modalities in terms of main aspects, where blue (Fast, Operator Independent 
and Accurate) and green (Economic) are desirable aspects, and red (Invasive) is undesirable. 
The diagram shows the relative location of all major modalities considered where the goal is 






Outside of breast self-exam, mammography is the most widely used and well-accepted 
technique to detect breast cancer, and is thus an effective gold standard in the field. However, 
its limitations in exposure to ionizing radiation and comfort due to breast compression, both 
of which can affect compliance to screening, create a significant need for other less invasive 
approaches. In addition, its variability in diagnosis based on radiologist experience may be a 
further limitation to be improved by automated methods, within mammography or via 
another modality. However, it is important to note that mammography is still the only proven 
and accepted wide scale screening modality. 
 
In contrast, current and emerging methods using ultrasound, thermography, MRI, and 
Microwave imaging all are non-invasive, but their reported results to date are too variable at 
this time for use in regular screening. Newer emerging technologies, like DIET and advanced 
ultrasound systems, can offer non-invasive, all age screening that is low cost. However, these 
latter emerging technologies still face a long validation process to prove their efficacy in 
relation to accepted standards before they are accepted as realistic screening alternatives and 
this thesis addresses some of validation process.  
 
Overall, this review concisely summarises the overall strengths, weaknesses, and thus gaps in 
the field, with a strong focus on how newer, emerging technologies can offer novel solutions 









Chapter 3: Mechanical behaviour of tissue mimicking 




Understanding the mechanical properties of soft tissues, particularly stiffness, is relevant for 
the diagnosis of many illnesses, such as liver, heart disease and breast cancer. The aim of this 
chapter is to determine which materials and compositions have appropriate elastic modulus 
and viscoelastic properties to accurately mimic the actual breast tissues for DIET over its 
frequency range (up to 100Hz) of inputs. Phantoms are an important aspect of diagnosis 
development and have not been properly investigated over the full range in past.  
 
To investigate the linear elastic properties of tissues, linear stress strain characteristics of 
agar, gelatin and silicone samples are studied by measuring small strains up to 5%. In this 
range, the phantom is assumed to exhibit linear elastic behaviour. Using Hooke‟s law, the 
elastic behaviour of phantoms can be characterized by its Young‟s modulus, and particularly 
its specific storage and loss moduli. More specifically, the viscoelastic behaviour of each 
material sample is investigated by subjecting the samples by varying dynamic input 
frequencies to assess the storage (E
’
) and loss modulus (E
”
), and thus elastic modulus of these 
materials using two proven measurement methods.  
 
Different compositions of each material are used to approximate breast tissues, as well as to 
determine hyper-elastic model parameters of selected materials with appropriate elastic 
modulii. This work also examines the effect of preload on strain level on each sample and 
composition, with results compared to real tissue results for the ratio between healthy and 




and repeatability of these materials, particularly with respect to environmental conditions and 
storage.  The fabrication process of breast shaped mimicking phantom of selected material is 




Demand for better screening modalities has driven growing interest in phantom materials to 
mimic breast tissue to aid research and design. A tissue-mimicking phantom should emulate 
important mechanical or radiological properties of biological tissue for the purpose of 
providing a more clinically realistic imaging test environment. These phantoms in-turn aid 
development and validation of new imaging techniques, such as elastography [26, 27, 36], 
which have different phantom requirements than non-contact imaging methods, such as MRI. 
Thus, the phantoms used may well be different and may, or may not, be multi-modality 
capable 
 
A multitude of tissue-mimicking materials and phantoms are described in the literature, 
created using a variety of materials and preparation techniques for a range of biological 
systems. Mixtures of agar and gelatin, polyacrylamide gel, paraffin-gel waxes, polyvinyl 
chloride (PVC), and polyvinyl alcohol (PVA) were used in tissue phantoms for 
ultrasonography [214-222]. Both agar and gelatin have excellent acoustic properties for 
ultrasound (US) elastography and would be suitable for both MR and US properties [223]. 
Sinkus et al [224] describe a breast phantom for MRI elastography made from polyvinyl 
alcohol. The bulk of these phantoms consist of a softer material surrounding a 6-mm cube of 




well as for validating acoustic approaches. However, they are not representative in shape, 
which is important when mechanical wave propagation plays a role. 
 
The DIET approach is mechanically based, and thus requires phantoms with mechanical 
properties to match tissue mechanical properties, as well as being created in a breast shape, as 
shape and location play a role in this diagnostic approach. Thus, most prior approaches would 
not be applicable in this more unique case, as well as making comparison difficult to prior 
phantoms due to differences in shape. Hence, this work focuses on the mechanical properties 
necessary for making a mechanical tissue mimicking phantom and does not have the scope to 
enable comparisons to other modalities. 
 
Tissue stiffness has been recognised as playing an important role in diagnosis of breast 
cancer, as tumour tissues have greater stiffness than the surrounding breast tissues [225]. This 
difference is the foundation of manual palpation and breast self-exam, which is remarkably 
effective. Unfortunately, only a few studies reporting the elastic properties of real breast 
tissue are available in the literature. Studies on the mechanical behaviour of breast tissue 
show the elastic modulus (E) ratio of adipose to tumour tissue ranges from 1:5 to 1:15, which 
is a relatively large contrast to leverage in diagnosis. 
 
Sarvazyan [226] found cancer can be 7 times stiffer than normal tissue. In contrast, 
Skovoroda [227] found a normal to tumour tissue ratio of 1:3. It is unclear what strain levels 
were used during these tests. Which will affect results significantly. Kroupkop [225] 
recognized the non-linear behaviour of breast tissues require the computation of an elastic 
modulus at more than one strain level. At 5% precompression strain, the ratio of normal to 




contrast, adipose and tumour tissues have similar elastic moduli at small strains (less than 
10%). Thus, while it might not be possible to distinguish malignant tumours from benign 
tumours at small strain levels alone, it may be possible by considering data at larger strain.  
These results are used in this work to guide the experimental analysis and use of pre-load to 
delineate the targeted material properties when formulating phantoms using these materials. 
Hence, one result of this work relates the phantom creation process and materials used to the 
outcome material properties, relative to the desired tissue properties in breast cancer. 
 
Several materials previously used to mimic breast tissues and their mechanical properties are 
close to those of breast tissue [228, 229]. Agar and agar/gelatin combinations have been 
commonly used to mimic the acoustic and elastic properties of soft tissues [215, 230-232]. 
Agar has also been used successfully to mimic organs, breast tissues, sinus cavities and 
vascular systems [230]. Agar, gelatin, and silicone are polymers with nonlinear behaviour 
and can provide similar stress-strain relationships to breast tissue [233]. Agar and gelatin are 
networks of polymer chains with covalent bonds and water filled interstitial space [234].  
They thus mimic the physiology of fluid sense tissues well. Silicone is comprised of linear 
chains of dimethylsiloxane and is also used for a range of biomedical products [235]. Hence, 




3.2 Materials and methods 
To determine the elastic properties of agar, gelatin, and silicone, sample tests were conducted 
using a MTS Criterion model C43.104 (MTS Systems Corporation, USA). The dynamic 




Q800 Dynamic Mechanical Analysis (DMA) (TA Instruments, USA). Procedures for sample 
preparation and testing are described in the following sections. 
 
3.2.1 Sample preparation 
Three different “tissue equivalent” material samples were prepared for testing of mechanical 
properties. Each material is commercially available, but may require mixing. The key 
materials used were agar, gelatin, and silicone. Sample fabrication procedures were followed 
from published reports [184, 236, 237]. 
 
While the literature provides a range of formulations for similar tissues in these materials 
[238-240], they were varied here to better obtain the desired properties. In particular, for 
Agar, the amount of solution (n-propanol and deionized water) containing agar powder 
(concentration ranges from 2-6 g) is varied. For silicone, the composition is varied by 
changing the percentage of silicone used from 40-299 g. For gelatin, a bloom value of 125 is 
used instead of 200, as is used in most literature cases the authors are aware of [241, 242], 
which should provide more accurate outcome elastic moduli in this case. 
 
Materials from each recipe were poured by injecting 10 ml of prepared solution into a 
cylindrical Perspex mould. When the samples cured, the bottom plate was carefully removed 
and unmould the samples with a uniform thickness and flat, smooth surfaces. Each material 
had three different recipes created to mimic skin, adipose, and much stiffer tumour tissue. 
The specific materials and constituent quantities are described in Table 3.1. 
 
Sample sizes for the MTS compression tests were 30 mm diameter to fit pre-existing moulds 




samples were 30 mm in diameter and 5 mm thick for silicone and gelatin. However, 30 mm 
diameter and 1 mm thickness was used for agar to avoid sliding on the test system 
compression plate. These sample sizes are the recommended dimensions from the DMA 
system user manual [243]. Figure 3.1 shows some typical samples.  
 
Table 3.1: Material quantities for mimicking different tissue 
 Agar [237] Silicone [184]  Gelatin [236] 
Skin  Agar = 4 g 
 n-propanol = 20 ml 
 Deionized water  = 97 ml 
 
 SoftGel A-341C = 55g 
 
 p-toluic acid = 0.294 g 
 n-propanol = 28.69 ml 
 Deionized water = 279.5 ml 
 125 Bloom gelatin = 35 g 
 Formaldehyde (37% by weight) 
= 3.33 g 
 Oil ( 50% Safflower + 50% 
Kerosene) = 98.6 ml 
 Detergent = 5.86 ml  
 
Adipose  Agar = 2 g 
 n-propanol = 20 ml 
 Deionized water = 97 ml 
 
 SoftGel A-341C = 192g 
 DC 200 Silicone (50cst) = 
299g 
 
 p-toluic acid = 0.133 g 
 n-propanol = 6.96 ml 
 Deionized water = 132.7 ml 
 125 Bloom gelatin = 10 g 
 Formaldehyde (37% by weight) 
= 1.53 g 
 Oil ( 50% Canola + 50% 
Kerosene) = 265.6 ml 
 Detergent = 12 ml 
 
Tumour  Agar = 6 g 
 n-propanol = 20 ml 
 Deionized water = 97 ml 
 
 A-341C = 40g 
 LSR-05 A and B = 60g 
 
 p-toluic acid = 0.346 g 
 n-propanol = 17 ml 
 Deionized water =328 ml 
 125 Bloom gelatin = 100 g 
 Formaldehyde (37% by weight) 
= 3.72 g 
 Oil ( 50% Safflower + 50% 
Kerosene) = 38.4 ml 
 Detergent = 2 ml 
 
g = gram, ml = milli litre, percentage (%) = by weight, SoftGel A-341C (Factor II, Inc., 
USA), LSR-05 A and B (Factor II, Inc., USA), DC 200 Silicone (Dow Corning Corporation, 
USA), Agar (Sigma-Aldrich, New Zealand), n- propanol (Fisher Chemical, USA), p-toluic 
acid (Sigma-Aldrich, New Zealand), 125 Bloom geletin (Sigma-Aldrich, New Zealand), 
Formaldehyde (Sigma-Aldrich, New Zealand), Canola (Pure Oil New Zealand Ltd, New 








Figure 3.1: Samples size (a) for static property testing using MTS-43, and (b) Viscoelastic 
property testing using DMA 
 
3.2.2 Mechanical property testing 
Compression tests of all three groups of materials were performed using MTS and DMA with 
preloads of 0.05 N, 0.1 N, and 0.2 N at room temperature (18 
o
C to 20 
o
C). These preloads 
were applied to improve contact between the compression plate and the surface of the 
samples. Using the pre-existing mould, there were 10 samples fabricated for each recipe used 
to mimic skin, adipose and inclusion tissues. For agar and gelatin, a fresh sample was used 
for each experiment, to avoid any time history dependent effects on their viscoelasticity. To 
ensure measurement reliability, each sample was tested five times and the mean of the 
resulting elastic and storage moduli were calculated for each material. 
 
To determine the hysteresis curve, a quasi-static uniaxial compression loading and unloading 
applied under a strain rate of +/- 0.5mm/min was performed. The elastic modulus of each 
sample was calculated during this quasi-static uniaxial compression. A 100 N load cell was 
used with the MTS machine to perform the tests. Due to the brittle nature of agar, initial 




strain for this material. While silicone and gelatin are more ductile, the compression tests 
were also stopped at 15% strain to simplify comparisons with agar samples. 
 
DMA testing is used to characterize the viscoelastic behaviour of materials. To measure the 
storage modulus, an oscillatory test using a frequency sweep method at room temperature 
was applied to each sample. The frequency was varied from 0.1-100 Hz with increments of 
12 Hz for gelatin and silicone, and 0.1-50 Hz with increments of 25 Hz for agar due to water 
content beyond 50 Hz samples slides.  
 
Polymers like agar, gelatin and silicone have nonlinear, elastic behaviour that can be 
represented by a hyperelastic model. Hyperelastic models, namely Neo-Hookean [244], 
Mooney Rivlin [244, 245] and Ogden [246] models, are fitted to data to capture the nonlinear 
characteristics of materials to provide insight into tissue stress strain curve nonlinearities. The 
parameters of the resulting identified hyperelastic model are extracted, which can also be 
obtained from or utilized in nonlinear elastography. 
 
 Neo-Hookean (NH) is the simplest hyperelastic model, and is the reduced version of the 
Mooney Rivlin model [244]. The stress-strain relationship is derived from the strain energy 
density function denoted . For the Neo-Hookean model, the strain energy density is given 
by the following equation: 
 
      (    ) (3.1) 
 





Mooney Rivlin [244, 245] is the material model are used to represent incompressible, 
isotropic and elastic materials. For the Mooney Rivlin model, the strain energy density is 
defined: 
 
      (    )     (    ) (3.2) 
 
Where     and     are the material constants for a 2 parameter model, which are determined 
empirically.  
 
The Ogden model [246] is popularly used to fit isotropic biological tissues. The Ogden strain 
density energy function is written in terms of principal strains instead of the invariants. For 
the Ogden model, the strain energy density is defined: 
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Where           and   is the stretch ratio and    and    are constants. The initial shear 
modulus is given as    ∑     
 
   .  
 
 
3.3 Results and discussion 
The elastic and viscoelastic properties of skin, adipose, and tumour sample made from all 
three materials are compared with preloads 0.05 N, 0.1 N, and 0.2 N. Elastic modulus, 
storage modulus, and loss modulus values for agar, gelatin, and silicone are summarized in 




literature, and mimicking materials with adipose to inclusion ratios are summarized in Table 
3.6 for comparison. 
 
3.3.1 Effects of preload on strain 
In biological tissue, the Young‟s Modulus cannot be assumed constant as a function of 
preload. The results in Table 3.2 show the effect of preload on strain on each sample of agar, 
gelatin, and silicone material. At all preloads of 0.05 N, 0.1 N and 0.2 N, pre-compression 
strain ranges from 0.3% -4.8%, 0.3% - 6% and 0.3% - 14.6% for agar, gelatin, and silicone, 
respectively. It can be noted that agar is stiffer as compared to silicone and gelatin. For all 
three materials, each adipose mimicking tissue sample has a higher pre-compression strain 
percentage compared to inclusion mimicking tissue sample because adipose mimicking tissue 
samples are softer than inclusion mimicking tissue samples. 
 
Table 3.2: Effects of preload on samples in MTS testing 
 
Pre-compression Strain % 
Preload 
(N) 
Agar Gelatin Silicone 
Skin Adipose Tumour Skin Adipose Tumour Skin Adipose Tumour 
0.05 0.4 1 0.3 0.3 1.5 0.3 0.3 3.3 0.5 
0.1 1 2.2 0.5 0.6 3 0.6 0.5 7.3 1.4 
0.2 2.2 4.8 1.1 1.2 6 1.3 1 14.6 3 
 
 
3.3.2 Elastic characterization using MTS 
Figure 3.2 shows the upper and lower portions for the quasi-static uniaxial compression 
loading and unloading cycle of all three material skin samples. Hysteresis curves show each 
material is viscoelastic. The energy dissipated during the loading-unloading cycle is given by 




more energy dissipation than agar. For elastic modulus measurements, only the loading part 
was considered. The elastic modulus of all three materials were calculated from the initial 
linear region up to 5% strain.  
 
Figure 3.2: Hysteresis curve of agar, gelatin, and silicone for MTS initial testing 
 
Figure 3.3 shows the loading stress strain behaviour of agar, gelatin and silicone samples for 
skin with preloads of 0.05 N, 0.1 N, and 0.2 N from which elastic modulus can be 
determined.  Elastic moduli for agar and gelatin for skin mimicking tissue sample increases 
with the increase of preload. However, the elastic modulus for silicone material for skin is 
independent of preload up to 0.2 N. Thus, a large preload would be required to achieve a 
greater elastic modulus.  
 
The elastic moduli of the skin samples for each group of materials are shown in Table 3.3. 
Mechanical properties of human skin depend upon skin thickness, stress applied to the skin 
during experiments, types of experiments, sex, and age. Elastic moduli of human skin 




properties of human skin in-vitro is not easy because removing it from its natural 
environment and pre-tensioning may cause changes in the mechanical properties. 
 
Figure 3.4 shows the loading stress strain behaviour of agar, gelatin and silicone adipose 
mimicking tissue samples with preloads of 0.05 N, 0.1 N, and 0.2 N.  The elastic modulus for 
silicone remain almost constant for adipose mimicking tissue sample with increasing 
increments of preload, similar to results in Krouskop et.al, where breast adipose tissue has a 
constant modulus over the strain range [225]. For agar, elastic moduli remain constant for 
preloads 0.05 N and 0.1 N, and then increase with a preload of 0.2 N. In addition, adipose 
mimicking tissue samples for gelatin significantly decrease with increasing preload. Thus, 
agar and gelatin are dependent on preload, unlike silicone. Results are summarized in Table 
3.3. 
 
Figure 3.5 shows the loading stress strain behaviour of agar, gelatin and silicone tumour 
mimicking tissue samples with preloads of 0.05 N, 0.1 N, and 0.2 N.  The stiffness ratio of 
adipose to tumour tissues plays an important role in how detectable the tumour is using 
elastography. It is the key to elastographic diagnosis. The elastic modulus of tumour tissues is 
much greater than adipose tissues [225]. All three tested materials for tumour mimicking 
tissue samples have greater elastic moduli than adipose mimicking tissue samples, as shown 







Figure 3.3: Stress-strain behaviour for all three materials for skin sample with: (a) preload 





Figure 3.4: Stress-strain behaviour for all three materials for adipose sample with: (a) preload 





Figure 3.5: Stress-strain behaviour for all three materials for tumour sample with:  (a) preload 




Table 3.3 shows the static property summary of all three materials. For preloads 0.05 N, 0.1 
N, 0.2 N, the adipose to tumour mimicking tissue sample ratio of silicone materials are 1:11, 
1:10, and 1:19. For gelatin they are 1:2, 1:3, and 1:5, and for agar they are 1:5, 1:9, and 1:2. 
The ratios for silicone materials are potentially better than those for gelatin and agar. Because 
as per literature [225, 248] the elastic modulus ratio of adipose to tumour tissue ranges from 
1:5 to 1:15. 
 
Table 3.3: Static property summary for all tests. Data shown as mean ±SD 
 
Elastic Modulus (E) in kPa 
Preload 
(N) 
Agar Gelatin Silicone 
Skin Adipose Tumour Skin Adipose Tumour Skin Adipose Tumour 
0.05 26±1 5±0.4 26±5 17±3 23±5 56±2 14±1 5±0.7 57±1 
0.1 27±5 5±0.8 46±7 26±4 18±2 63±7 15±0.3 6±0.6 59±9 
0.2 49±3 33±0.2 81±10 28±5 17±3 85±19 15±0.3 6±0.4 112±10 
 
 
3.3.3 Viscoelastic characterization using DMA 
The viscoelastic behaviour of soft tissues can be measured by applying a periodic 
compression to a uniform thickness and cross sectional cylindrical/disc sample. The complex 
elastic modulus is defined: 
 
E* = Eʹ+ iEʺ (3.4) 
 
The real part of the complex modulus (Eʹ) is called the storage modulus, representing the 
elastic portion, as it measure the stored energy. The imaginary part (Eʺ) is called the loss 
modulus, representing the viscous portion, as it measure the amount of dissipated energy. The 




loss modulii together help define the overall stiffness and dissipative properties of the 
material, dynamically. 
 
The results of frequency sweep tests on the DMA for all three materials are shown in Figures 
3.6-3.8 with preloads 0.05 N, 0.1 N, and 0.2 N. These figures show all the measured values of 
storage modulus and loss modulus by varying the frequency from 0.1-100 Hz for gelatin and 
silicone, and from 0.1-50 Hz for agar. Tables 3.4 and 3.5 show the storage modulus and loss 
modulus at 0.1 Hz frequency for all three tested materials. 
 
Figure 3.6 shows the storage and loss modulii of agar, gelatin and silicone skin mimicking 
tissue samples with preloads of 0.05 N, 0.1 N, and 0.2 N. The storage modulus at 0.1Hz for 
agar and silicone skin mimicking tissue samples gradually increases with preloads of 0.05 N, 
0.1 N, and 0.2 N. Whereas the storage modulus for gelatin skin  mimicking tissue sample 
remains constant at 0.1Hz with all three preloads. It is noted that the storage modulus of 
gelatin skin mimicking tissue samples remain stable with frequency over the range of 0.1-10 
Hz and variable near to 100 Hz for every preload value. The storage modulus remains almost 
same with frequency from 1-90 Hz for silicone skin mimicking tissue samples, and shows 
small variability near to 100 Hz for every preload value. In addition, for agar skin mimicking 
tissue samples, the observed storage modulus gradually increases with frequency from 1-10 






Figure 3.6: Variation of storage and loss modulus for all three materials for skin sample with:  




Figure 3.7 shows the storage and loss modulii for agar, gelatin and silicone adipose 
mimicking tissue samples with preloads of 0.05 N, 0.1 N, and 0.2 N. The storage modulus at 
0.1Hz for gelatin and silicone adipose mimicking tissue samples remains constant for all 
three preloads. In contrast, the agar adipose mimicking tissue sample gradually increases with 
increasing preload. The storage modulus for gelatin and silicone for adipose mimicking tissue 
samples remains stable with frequency over the range of 0.1-70 Hz with preload 0.05 N, 0.1 
N, and 0.2 N. For agar adipose mimicking tissue samples are gradually increase with 
frequency from 0.1-25 Hz with all three applied preloads. 
 
Figure 3.8 shows the storage and loss modulii for agar, gelatin and silicone tumour 
mimicking tissue samples with preloads of 0.05 N, 0.1 N, and 0.2 N and shows greater 
storage modulus for the tumour mimicking tissue samples compared to the skin and adipose 
mimicking tissue samples for all three materials. In addition, as the sample is more 
compressed, the storage modulus increases at frequency 0.1Hz. Gelatin material for tumour 
mimicking tissue samples show stable results with frequency range of 0.1-10 Hz, but become 
unstable near 100 Hz. For agar, the tumour mimicking tissue sample gradually increases from 
0.1-25Hz and decreases near to 50 Hz. There is no noticeable variation in storage modulus 










Figure 3.7: Variation of storage and loss modulus for all three materials for adipose sample 






Figure 3.8: Variation of storage and loss modulus for all three materials for tumour sample 





The storage modulus ratios over all three preloads of adipose to tumour mimicking tissue 
samples for silicone materials are 1:5, 1:11, and 1:12. For gelatin they are 1:3, 1:3, and 1:11. 
For agar they are 1:4, 1:8, and 1:3. The ratios for silicone materials are better than those for 
gelatin and agar, due to their values being relatively close to what has been reported in real 
breast tissues, as summarized in Table 3.6.  
 
Table 3.4: Storage modulus summary for all tests at 0.1Hz. Data presented as mean ±SD 
 
Storage Modulus (E’) in kPa 
Preload 
(N) 
Agar Gelatin Silicone 
Skin Adipose Tumour Skin Adipose Tumour Skin Adipose Tumour 
0.05 4±0.2 3±0.1 14±2 32±6 10±0.1 36±7 8±2 5±0.7 24±3 
0.1 20±4 10±0.4 83±7 35±2 10±0.2 35±8 16±4 6±0.4 68±5 
0.2 91±10 37±2 128±15 35±4 10±0.6 109±9 23±0.01 6±0.3 73±0.08 
 
 
Table 3.5: Loss modulus summary for all tests at 0.1Hz. Data presented as mean ±SD 
 
Loss Modulus (E”’) in kPa 
Preload 
(N) 
Agar Gelatin Silicone 
Skin Adipose Tumour Skin Adipose Tumour Skin Adipose Tumour 
0.05 2±0.3 0.3±0.04 1.4±0.3 22±4 2±0.8 18±0.8 4±1 0.6±0.1 1.4±0.2 
0.1 3±0.5 6±1 18±0.4 17±2 4±0.6 24±5 0.7±0.2 0.3±0.08 11±2 
0.2 19±3 11±2 26±0.6 27±1 3±1 34±5 3±0.5 0.06±0.02 12±4 
 
It can be noted that storage modulus is always ~20 times larger than the loss modulus for all 
frequencies. This result is similar to the behaviour of biological tissues [225]. For an agar 
concentration of 2g (adipose mimicking tissue sample) and 4g (skin mimicking tissue 
sample) at preloads of 0.05 N, 0.1 N and 0.2N, the loss modulus values are uniformly lower 




samples, but matches results in [249]. In general, the loss modulus increases with the increase 
of agar and gelatin concentration. For silicone, the loss modulus of adipose mimicking tissue 
samples are smaller than in the skin and tumour mimicking tissue samples, which matches 
expectations and prior reports [184]. 
 
Mechanical properties of real breast tissue, as reported in the literature, and mimicking 
materials with adipose to tumour ratio are summarized in Table 3.6 for comparison. The 
absolute values of elastic modulus and storage modulus are not very comparable to that of 
real tissue, because of the different pre-compression and preload values applied in their 
experimental methods and also different measurement methods [225, 248]. It is obvious that 
real human breast tissues are more complex and heterogeneous. Thus, it is very hard to 
achieve the same absolute values. However, the ratio of moduli for adipose to tumour sample 
in this work compares very well to that of real breast tissue, and this ratio is the key for 
diagnosis. Hence, absolute values that are close with good matches to ratios will provide a 
good phantom. 
 
Table 3.6: Storage modulus in kPa summary of real breast tissues from literature and 
mimicking materials at 0.1 Hz  





5% 18±7 22±8 1:1 
20% 20±8 291±67 1:15 
Real Breast 
Tissues [248] 
3 g 3.25±0.9 16.38±1.5 1:5 
Agar 
0.05N 3±0.1 14±2 1:5 
0.1N 10±0.4 83±7 1:8 
0.2N 37±2 128±15 1:3 
Gelatin 
0.05N 10±0.1 36±7 1:3 
0.1N 10±0.2 35±8 1:3 
0.2N 10±0.6 109±9 1:11 
Silicone 
0.05N 5±0.7 24±3 1:5 
0.1N 6±0.4 68±5 1:11 





According to [225], adipose breast tissue has a constant modulus over the strain range and the 
elastic modulus of tumour tissues is highly dependent on the level of tissue pre-compression 
used in the measurement. For example, the elastic modulus of tumour tissue was found to be 
5 and 15 times larger than that of normal adipose tissue when applying pre-compression 
levels of 5% and 20%, respectively. This dependence confirms the nonlinear elastic 
behaviour often observed in biological tissues [225].  
 
Similarly, the gelatin and silicone adipose mimicking tissue sample data in this study has 
almost constant storage modulus at all preloads, and tumour mimicking tissue samples were 
also similarly dependent on the preload. However, the effect of preload on agar mimicking 
tissue samples is unlike silicone and gelatin. At all agar concentrations (2-6 g) there is a 
significant variation in storage modulus at 0.1 Hz frequency at all three preloads. In 
summary, agar materials can be used as tumour tissue phantoms with additional agar 
concentration to obtain the right material properties and ratios.    
 
Overall, elastic moduli and storage moduli of all three materials in mimicking of skin, 
adipose and tumour tissue samples is summarized in Tables 3.3 and 3.4. It is notable that for 
agar and gelatin, the mechanical properties depend on the concentration. Thus, increasing the 
agar and gelatin concentration increases the stiffness of the sample. This control allows 
different tissue types to be mimicked based on their different tissue stiffness in vivo.  
 
In gelatin based phantoms, apart from increasing the concentration of gelatin, it is possible 
that the use of formaldehydes to increase the melting point of the gel. This approach 
simultaneously increases the resulting material stiffness, as formaldehyde can be used to 




depend not only on the dry-weight concentration used in the mixture, but also on the Bloom 
value of the gelatin used.  
 
Agar mechanical and imaging characteristics can be achieved similar to those of soft tissues. 
This goal is achieved by adjusting concentration and the amount of liquid solution. Its main 
limitation is its low toughness, making it fragile during handling. For silicone, the properties 
are a function of the creation process, such as curing time and the amount of silicone used as 
a percentage.  
 
The results presented provide guideline ranges for custom tailoring the material properties 
towards the intended values and/or ratio of tumour to healthy tissue properties, where specific 
outcomes or formulations depend on the range of factors presented. However, overall, the 
results show what is possible and how these properties vary across frequencies not typically 
considered in these phantom materials. All material samples were stored in a controlled 
environment to avoid dehydration during experiments. 
 
3.3.4 Hyperelastic characterization  
The stress strain curve of polymer materials have two regions, an elastic region in the initial 
portion of the curve and a hyperelastic region where material exhibits more stress for a small 
increment in strain. After the results and discussion presented, silicone material is selected as 
a best choice because of its appropriate elastic and viscoelastic properties. The next step is to 
find hyperelastic parameters by fitting uniaxial compression experimental data for silicone 
based skin, adipose and tumour mimicking tissue sample into the Neo-Hookean, Mooney 
Rivlin and Ogden models. The results are shown with mean experimental stress strain data in 
Figure 3.9 and computed parameters with goodness of fit (R
2





Figure 3.9: Neo-Hookean(NH), Mooney Rivlin(MR), Ogden models are fitted to 
experimental stress strain data for Silicone (a,d,g) Silicone skin tissue sample preload 0.05, 
0.1, 02 N (b,e,h) Silicone adipose tissue sample preload 0.05, 0.1, 02 N (c,f,i) Silicone 






Table 3.7: Summary of hyperelastic models for silicone material 
Preload Models Skin    Adipose    
Tumou
r 
   
0.05 N 
Ogden (kPa) 







   11.12 9.61 10.52 
MR (kPa) 







    -10.04 -3.41 -39.28 
NH (kPa) 
    
2.51 0.986 0.88 0.992 9.79 0.988 
0.1 N 
Ogden (kPa) 







   9.17 8.87 13.35 
MR (kPa) 







    -9.75 -3.26 -49.74 
NH (kPa) 
    
2.81 0.993 0.94 0.994 8.589 0.974 
0.2 N 
Ogden (kPa) 







   6.23 7.21 2.33 
MR (kPa) 







    -6.38 -1.96 1.50 
NH (kPa) 
    
2.36 0.997 0.67 0.997 15.50 0.998 
 
The Ogden and Mooney Rivlin model appeared to be the most suitable choice for predicting 
the behaviour of a given silicone composition because of its ability to match experimental 
data points at small and large strain values. It can be noted that the goodness of fit (  ) of 
Neo-Hookean model is less than the other two models, but all are excellent. Since we 
consider uniaxial isotropic material behaviour predominantly in elastography, the Mooney 
Rivlin model could be used for fitting the experimental curve of the prepared skin, adipose 






Overall, this work has established hyperelastic models for characterizing constitutive 
relations of silicone based samples and computed parameters. These parameters could be 
used as input in finite element hyperelastic simulation of silicone based breast phantoms and 
modelling of silicone breast tissue. Hence, they enable better elastographic analysis, as well 
as enabling better finite element modelling. 
 
 
3.4 Environmental effects on samples 
When agar material samples were stored in a controlled environment at approximately 20 
o
C, 
within a week all samples developed a fungal growth. This growth is due, in part, to the 
availability of water in the samples.  
 
Gelatin mimicking tissue samples for skin, adipose, and tumour were mixed with different 
water and oil concentrations to change the elastic modulus and storage modulus values. 
Gelatin materials show appropriate mechanical properties in terms of stability in the storage 
modulus with the range of frequencies in DMA testing. However, because of its high water 
content, relative humidity will effect mechanical properties over time, as evaporation over 
longer term storage means its mechanical properties change. Thus, such a phantom cannot be 
used for long term, reuse, and comparison. 
 
Silicone materials are thus more attractive than agar and gelatin because of their stable 
material properties and fungal resistance. Greater consistency means they can be used for 
long term testing and reuse. Hence, they could be used for repeated testing over longer 
periods, so different elastographic systems could be compared with the same ground-truth. 




samples. In summary, the overall advantages and disadvantages of each material are outlined 
in Table 3.8. 
 
 
Figure 3.10: Environmental effect on samples with significant fungal growth on agar and 
gelatin 
 
Table 3.8: Mechanical property summary for all tests 
Materials Advantages Disadvantages 
Agar 
 Easy to prepare 
 Takes 20min to solidify in 
open air 
 Ranges of moduli can be 
achieved by varying agar 
concentration 
 
 Brittle in nature 
 Effected by environmental 
influences e.g fungus 
 Slides and leaks water 




 Ranges of moduli can be 





 Effected by environmental 
influences e.g fungus 
 Take approximately 5 hour 
to prepare sample and 
solidify  
Silicone 
 Easy to prepare and cure 
 Good mechanical properties 








3.5 Breast shaped silicone phantom fabrication  
Symmetric breast shaped silicone phantoms were fabricated using a core and cavity mould. 
For skin mimicking tissue phantom total amount of 55g of 100% A341 solution has been 
used. A vacuum chamber was used to remove air bubbles from the silicone. The solution is 
poured onto the breast shaped cavity and the mould is placed on top of it. This produces a 
thin and uniform 1 mm thick skin layer. The skin is cured at 60 
o
C within an hour. 
 
Once skin layer is cured the core can be removed, a Perspex plate is placed on top of the 
cavity with a support of two plates. Nylon bolts are attached for ease of handling and 
clamping during experiment on DIET machine.  
 
For adipose mimicking tissue phantom 192g of A341 and 299g of DC 200 solution has been 
used and mixed properly. The mixture is then placed inside the vacuum pump to remove 
bubbles and then poured into the cavity mould. The adipose mimicking tissue phantom 
material is cured at 60 
o
C within two hours. Once the adipose mimicking tissue silicone 
phantom is cured, the breast shaped phantom can be easily removed from the mould cavity.  
 
For tumour mimicking tissues phantom, 40g of A341 and 60g of LSR-05 was used. Three 
different sizes of tumour mimicking tissue were fabricated in spherical shapes of 20 mm, 10 
mm and 5 mm diameter. Both materials are mixed well and placed inside the vacuum pump 
to remove bubbles. The mixture is then poured with syringe into the tumour mould and 
placed inside the oven to cure at 60 
o
C for three hours. The tumour mimicking tissue phantom 
is then suspended from a support in by a wire into the breast cavity to create an inclusion.  






Figure 3.11: Fabrication process of silicone breast shaped phantom: (A) Procedure of core 
extraction (B) Cured skin layer (C) Perspex plate (D) Tumour with different diameter sizes 





Human breast tissues are complex and replicating their mechanical properties in the 
laboratory can be very challenging. The aim of this chapter was to find the most suitable, 
commonly available material to mimic breast tissue for use in elastography. In summary, all 
presented materials are suitable for tissue-mimicking phantoms under different conditions. 
However, there are various drawbacks of agar regarding its utility in stable homogenous 
phantoms: (1) Agar is a brittle gel that can fracture with moderate strains; and (2) it exhibits a 
much more rapidly increasing elastic modulus with preload than normal breast tissues, where, 
in contrast, agar and gelatin are over 80% water and have a stiffness similar to that of soft 
tissue. Thus, because of water content in agar and gelatin, they have limited durability due to 




application over several days or weeks, limiting their usefulness in creating tissue mimicking 
phantoms for this application. 
 
Silicone is a soft tissue material with an appropriate elastic modulus ratio of adipose and 
tumour mimicking tissue sample. It is easy to prepare samples with a range of mechanical 
properties and it is fungal resistant. Measured elastic moduli for silicone mimicking tissue 
samples range from 5-112 kPa and storage moduli range from 5-73 kPa for all normal and 
tumour mimicking tissue samples. The stiffness ratio of adipose to tumour for silicone 
mimicking tissue samples range from 1:5-1:12 compared with the real human breast tissues 
range from 1:1-1:15. Additionally, experimental data from uniaxial compression tests of skin, 
adipose and tumour mimicking tissue samples were obtained to input into finite element 



















Chapter 4: Finite element modelling and validation 




The fabricated breast shaped phantom dimensions and hyper-elastic properties from Chapter 
3 were used to construct a biomechanical finite element (FE) model of breast shaped 
phantoms. An accurate model could be used to more rapidly generate motion data. Such 
models do not currently exist, but would enhance development of this screening technology. 
This Chapter presents the development of a finite element model approach to analyse breast 





The modelling of biomechanical tissue properties has gained considerable interest in a range 
of clinical and research applications. Finite element (FE) modelling enables analysis and 
evaluation of structures and systems for which there are no theoretical models or solutions 
because of the complexity of the material properties and boundary conditions. Yu-Neifert 
[250] was one of the first to model breast tissue movement to determine the applicability of 
holographic interferometry in breast cancer detection. Kita et al. [251] created breast model 
of deformations under mammographic compression. 
 
In 2000, Azar et al. [252], constructed a finite element model of the breast from MR data to 




compression. They then compressed the finite element model. This method helped guide a 
clinician in a breast biopsy to sample the right region of tissue. In 2001, Samani et al. [253] 
also constructed 3D finite element models of the breast using MRI data to perform mesh 
convergence studies to assess the accuracy of the model.  
 
Several studies on mechanical properties of the breast have been investigated to evaluate 
deformation of the breast under external compression [254-257]. In a recent study, image 
data were collected from ten patients who had undergone mammography screening and MRI 
screening. The breast models were created from MR images and relationships between 
compressed breast thickness, breast volume, glandularity, and compression force were 
provided for use in clinical mammography [258].  
 
In biomedicine, some other recent applications of FE modelling include guiding clinical 
biopsies [259] and further models of modelling high strain tissue compression [258]. It has 
also been applied for use with X-ray mammography to localize mammogram identified 
inclusions [260, 261], as well as registering for X-ray and MR mammography, validating 
non-rigid registration algorithms [262], and testing reconstruction algorithms for elastography 
[263]. Hence, FE models have a long history in the broad area of breast cancer screening and 
medical imaging. 
 
DIET was initially developed and its first potential proof-of-concept using physical silicone 
phantoms [30, 184, 185]. However, a trial-and-error experimental approach can be time 
consuming when developing algorithms to analyse surface motions and create diagnostic 
metrics. This issue is particularly valid when testing new phantom cases is necessary, as an 




behaviour of these phantoms, would enable in-silico development of analytical diagnostic 
metrics for DIET without phantoms, as well as for any similar elastography methods for any 
similar type of phantom. Similarly, successful computational models and methods for 
simulating this type of physical phantom would be a first step in translation to modelling 
human breast tissues for similar research and development goals. 
 
Thus, for diagnostic development, a finite element model of these phantoms, if it was able to 
provide the same motion data as a phantom, would enable far more rapid analysis and 
diagnostic development. In particular, it is far faster and easier to develop and run a finite 
element model of a phantom in a given configuration, with/without inclusions, than it is to 
develop and fabricate the phantom and then to test it physically. However, while finite 
element methods have been used extensively in areas related to breast cancer, there are no 
studies on this modelling for use in mimicking the mechanical properties of breast tissue or 
breast tissue phantoms for elastography. The closest prior work is that of Nielsen et al [261, 




4.2 DIET experimental data 
The DIET system images a range of breast shapes and sizes, so the position of the breast and 
actuator in each image varies between trials. Spherical coordinates (r,θ,φ) are used to estimate 
a parametric 3D model of the breast surface from frame images, for each of the k = 10 frames 
imaged over one harmonic cycle of actuation [30, 184, 188]. A grid of reconstructed 3D 
surface points is then projected onto the breast image. To estimate surface motion of these 




on a breast phantom moving in a single loop direction in response to sinusoidal input after 
k=10 frames in a response cycle. One motion set includes ~15000 points on the surface of 
each phantom or breast multiplied by 10 measured points per sinusoidal response cycle [188]. 
While silicone phantom experiments are important in development, they were not intended to 
perfectly represent the breast. However, the material properties of the silicone used, and their 
fabrication, are designed to mimic realistic breast tissue properties and overall structure [184, 
185] as described in Chapter 3. Silicone with approximately 4 times greater stiffness than that 
used to mimic healthy tissue [225] is used to represent stiffer lesions or inclusions, as shown 
in Figure 4.1. Overall, these phantoms capture essential shape, as well as healthy and 
inclusion material properties, to provide a realistic phantom for development. 
 
Figures 4.1 as per caption under the figure defines the 3 phantoms used in this study, 
including the no inclusion healthy case. Data from 28 Hz, 30 Hz, and 32 Hz sinusoidal input 
frequencies with 1 mm amplitude are considered. These are the middle frequencies of DIET 
machine as described in Chapter 2. In each case, a two Newton (2N) preload is also applied, 







Figure 4.1: A total of three phantoms were constructed, a healthy (no inclusion), with a 10 
mm inclusion and a 20 mm inclusion (a) Phantom in the DIET prototype and also shows 
geometry, dimensions, boundary conditions, and loading direction, the top of the phantom is 
fixed in all translations and rotations direction X=Y=Z=XR=YR=ZR=0 and also actuator 
displacement is on Z direction and X and Y translations and all three rotations (XR, YR, ZR) 
are fixed (b) Points on the breast motion after 10 frames, each frame represents different 
colour (c) Summary of two phantoms with a position of 20 mm and 10 mm inclusions (top 
view) – two phantoms were created and in each phantom there were 20 mm  and 10 mm 
inclusion were inserted 
 
 
4.3 Finite element modelling 
FE modelling is implemented in ABAQUS version 6.14 (ABAQUS Inc., Johnston, Rhode 
Island, United States). 
 
4.3.1 Geometry 
The FE model geometry has the same dimensions as the fabricated phantom shown in Figure 




phantoms, spheres of 10 mm and 20 mm diameter were created and inserted to mimic an 
inclusion. Their location is also shown in Figure 4.1. 
 
4.3.2 Boundary conditions and input loading 
Boundary conditions represent the initial conditions applied to the model. Fixed boundary 
conditions are applied to nodes on the chest wall. The second boundary condition is at the 
actuator. The displacement of the actuator is strictly vertical, and thus, X=Y=XR=YR=ZR=0 
for X and Y translations and all three rotations (XR, YR, ZR).  
 
To mimic conditions in the actual DIET system operation, a vertical, static force of 2N is 
applied as a preload along the actuator z-axis, to ensure contact with the breast is maintained. 
Note this compressive force on the phantom improves the repeatability of results [265]. A 1 
mm peak-to-peak input displacement is then applied on z-axis at 28 Hz, 30 Hz and 32 Hz. 
 
4.3.3 Mesh convergence 
3D solid elements were defined in the breast phantom volume, including for the inclusions 
where necessary. The challenge is defining the finite-element mesh that best mimics the 
structure of the breast shaped phantom in simulation, while minimizing model size and 
complexity. Soft breast tissue is assumed to show incompressible behavior [266]. Thus, a 3D 
free mesh was assembled using quadratic tetrahedral ten-node (C3D10M - Continuum 
3Dimensional 10-node Modified)  
Elements, as shown in Figure 4.2. These elements are especially attractive for complex models 





Figure 4.2: Tetrahedral elements, a 10 node quadratic tetrahedral element [268] 
 
DIET experimental results provide phantom surface motion displacement information. Mesh 
convergence was thus assessed based on these nodal displacements, which is what the model 
will be judged upon in comparison. The analysis goal is to determine the mesh resolution 
yielding an accurate (within 5%) prediction of the measured static deformations for the initial 
loading conditions.  
 
Thus, the modeled displacement of the 2N applied preload was recorded for each node on the 
surface of the modelled breast phantom. These nodes are expected to compress due to this 
loading condition. The deformation variation was calculated for each mesh refinement to 
choose the correct mesh size to validate the breast model. Element size was varied from 2-10 
mm. Figure 4.3 and 4.4 show FE models with 2-4 mm elements had similar results lower than 
the tolerance. Thus, FE models with 4 mm elements were used for further analysis. The 







Mesh 10 mm 
No. of Nodes : 4078 
No. of Elements : 2615 
 
 
Mesh 8 mm 
No. of Nodes : 8015 







Mesh 6 mm 
No. of Nodes : 16333 
No. of Elements : 11109 
 
 
Mesh 4 mm 
No. of Nodes : 56611 







Mesh 2 mm 
No. of Nodes : 358978 




Figure 4.3: Mesh convergence study 
 
 
Figure 4.4: A plot of maximum displacement versus mesh size shows the changes in 




4.3.4 Material properties 
Each element is assigned material properties corresponding to healthy and stiffer inclusion 
silicone phantom tissues. Hyper-elastic materials are well adapted to simulate soft tissue 
deformation. Based on Chapter 3, a Neo-Hookean hyper-elastic model is chosen to simulate 
these breast phantom tissues [264, 269]. Most biological tissues are also considered isotropic, 
homogenous, and incompressible. With these assumptions, it is possible to define the 
mechanical behavior of breast phantom tissue using a single elastic modulus, E, with neo-
Hookean properties, which is the reduced version of the Mooney Rivlin model [244], with    = 
0.67 kPa for fat tissue and    = 15.0 kPa for cancerous tissue [185]. 
 
 
4.4 Model validation 
In this section, the k = 10 frame radial displacement magnitudes from the sinusoidal response 
are compared first. These absolute values provide a dynamic size validation per frame of the 
sinusoidal response. They thus assess whether the overall material properties and model yield 
the expected magnitude of response. If each frame size is matched well, then the overall 
properties and model are essentially valid. The overall trend and sign across the frames of these 
cycles are validated using a cross correlation coefficient. The second step assesses the specific 
trend and profile of the dynamic response, which is what is processed for diagnostic analysis in 
DIET. It is thus critical this overall dynamic response shape matches well, even if magnitudes 
are not perfect. This combined method thus validates first the overall size of response, model 
structure, and material properties, and second, the dynamic trajectory from frame to frame for 





4.4.1 Frame to frame radial displacement magnitude 





















) relative to the input motion, creating k=10 
images per cycle. Over a phantom, one motion set includes ~15000 points on the surface 
multiplied by 10 time or phase points. However, the FE model mesh has 4200 surface points. 
For validation, the DIET motion set is reduced from ~15000 surface points to the nearest 4200 
FE model mesh points, each of which are then compared over the k=10 time points.  
 
Figure 4.5 shows how the frame to frame radial displacement for each of the resulting 4200 
points is calculated for each k = 1…10 frame using: 
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Where    
 is the frame to frame radial displacement and        are number of frames 
and   = 1…4200 are number of points. The overall average values over all   = 10 frames are 
also compared: 
 
    
 
  
∑    
 
  
   
 (4.2) 
 
For the first validation, experimental phantom and model responses are compared at each of 







Figure 4.5: Frame to frame displacement for each of the   = 1…4200 surface points 
 
4.4.2 Cross correlation and accuracy of the dynamic trajectory 
For the second validation, the cross correlation coefficient is used to validate the similarity of 
dynamic trajectory across both data sets. All cross correlation coefficients range from -1.0 to 
+1.0. A correlation coefficient of +/- 1.0 indicates a perfect correlation or inverse correlation 
between the two variables, and thus both variables increase and decrease together or oppositely, 
perfectly. A correlation coefficient of 0.0 indicates zero correlation, or no relationship, between 
the two variables.  
 
The vectors    ⃗⃗ ⃗⃗  ⃗ across all   = 1…10 frames for experiment and FE model are compared, for 
all   = 1…4200 surface points, where the    ⃗⃗ ⃗⃗  ⃗ vectors are defined for both experiment and FE 
model from Equation (4.2). Thus,    ⃗⃗ ⃗⃗  ⃗ (         )      
      
      
   , where the   ⃗⃗⃗⃗  
vectors are defined for both experiment and FE model. 
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Where    ⃗⃗ ⃗⃗  ⃗  (   )    ⃗⃗ ⃗⃗  ⃗ (   ) is the inner or dot product, and ‖   (   )‖‖   (   )‖ is the 




The geometry of the model is constructed from fabricated phantoms, and its mechanical 
properties were used from previous Chapter 3. This method allows the breast to capture surface 
motion at frequency ranges from 16 Hz to 50 Hz. In this chapter, from DIET frequencies range 
only three middle frequencies 28 Hz, 30 Hz, and 32 Hz are used as inputs to the beast shaped 
phantom modeled. Mesh convergence studies were performed to ensure that the numerical 

















Chapter 5: Validation of finite element modelling with 




In this chapter, the FE models from Chapter 4 are simulated and compared to DIET 
experimental data at three different frequencies, 28 Hz, 30 Hz and 32 Hz. The two described 
validation procedures; a frame to frame radial displacement magnitude and a cross correlation 
coefficient methods for over 4000 surface points with total of 10 number of frames on each 
model a healthy (no inclusion), 10 mm inclusion and 20 mm inclusion from Chapter 4 has 







This chapter presents the validation of finite element model approach to analyze breast 
shaped silicone phantoms with and without stiffer inclusions used to mimic cancerous 
lesions. A novel biomechanical and application-motivated model validation methodology is 
presented. This method is based on surface displacements of the breast phantom, which are 
the key to the diagnostic metrics in the DIET concept. In particular, validation focuses on the 
requirement for this model to capture the dynamic, steady state response at all phases of the 
sinusoidal response, rather than just matching amplitudes. This approach captures the need 




5.2 Frame to frame radial displacement magnitude validation 
Figures 5.1-5.9 show frame to frame validation results for each of the k = 1 … 10, FE and 
DIET radial displacement frames(   
 ). The maximum displacement on the color bars was 
fixed to 0.5 mm matching the positive peak amplitude of the 28 Hz, 30Hz and 32 Hz input 
sine waves. All figures show larger displacements by the actuator and smaller to zero at the 
chest wall, as expected, given the boundary conditions. 
 
Figures 5.1-5.3 show the displacement comparison for the healthy phantom at 28 Hz, 30 Hz 
and 32 Hz, respectively. Because the phantom is homogenous with no inclusion, the 
displacement is evenly distributed. The displacement near the actuator is high is due to input 
sine wave was applied on the actuator. Additionally, a fixed boundary condition was applied 





Figures 5.4-5.6 show the displacements for the 10 mm inclusion phantom. Because the 
changes in surface displacement are smaller, it is harder to see a difference between the 
region where the 10 mm inclusion is located and the surrounding tissues. Thus, it cannot be 
detected in this fashion, although advanced processing does detect it [30].  
 
Similarly, Figures 5.7-5.9 show the displacement comparison for the phantom with a 20 mm 
inclusion at 28 Hz, 30 Hz and 32 Hz. Tissue stiffness plays an important role for diagnosis of 
breast cancers in this DIET concept, as inclusions are 4-10 times stiffer than the surrounding 
breast tissues [270] as discussed in Chapter 3. The tissue displacements are inversely 
proportional to the stiffness of the tissue, and thus a stiffer region of tissue exhibits smaller 
displacements than a more compliant region, all else equal [27, 28]. Figures 5.7-5.9 indicates 
the position of the 20 mm inclusion with a black circle. Again, qualitatively the match is 
good, but there are small local differences in magnitude due to imperfect match of 
experimental phantom and model stiffness or damping properties, or other modelling errors. 
However, the frame to frame magnitudes qualitatively match well. As with Figures 5.4-5.9, 










Figure 5.1: Displacement distribution (all units in mm) of healthy phantom at 28 Hz for 
experimental DIET (left) and FE model (right) for the k=1…10 frames captured (top-bottom) 
- displacement distribution from frame 2 to 3 near the actutor is uneven, indicated by a black 










Figure 5.2: Displacement distribution (all units in mm) of healthy phantom at 30 Hz for 
experimental DIET (left) and FE model (right) for the k=1…10 frames captured (top-bottom) 
- displacement distribution from frame 3 to 4 near the actutor is uneven, indicated by a black 










Figure 5.3: Displacement distribution (all units in mm) of healthy phantom at 32 Hz for 









Figure 5.4: Displacement distribution (all units in mm) of 10 mm inclusion phantom at 28 Hz 










Figure 5.5: Displacement distribution (all units in mm) of 10 mm inclusion phantom at 30 Hz 










Figure 5.6: Displacement distribution (all units in mm) of 10 mm inclusion phantom at 32 Hz 










Figure 5.7: Displacement distribution (all units in mm) of 20 mm inclusion phantom at 28 Hz 
for experimental DIET (left) and FE model (right) for the k=1…10 frames captured (top-











Figure 5.8: Displacement distribution (all units in mm) of 20 mm inclusion phantom at 30 Hz 
for experimental DIET (left) and FE model (right) for the k=1…10 frames captured (top-










Figure 5.9: Displacement distribution (all units in mm) of 20 mm inclusion phantom at 32 Hz 
for experimental DIET (left) and FE model (right) for the k=1…10 frames captured (top-
bottom) position of 20 mm inclusion indicated with a black circle 
 
Figures 5.10-5.12 show the average radial displacement at 28 Hz, 30 Hz and 32 Hz of each 
node on the phantom surface (   ) to locate the 10 mm and 20 mm inclusion with a black 
circle. The average radial displacement reduces with the increasing frequency enabling the 




experimental and FE model results, as well as in motion amplitudes (average radial 
displacement), where all k= 1…10 frames are considered.  
 
Figure 5.10: Average radial displacement distribution (all units in mm) for 28 Hz frequency 
(a) DIET Healthy phantom, (b) Finite element analysis (FEA) Healthy phantom, (c) DIET 20 
mm inclusion position indicated with a black circle, (d) FEA 20 mm inclusion position 
indicated with a black circle, (e) DIET 10 mm inclusion position indicated with a black circle 
and (f) FEA 10 mm inclusion position indicated with a black circle 
 
Figure 5.11: Average radial displacement distribution (all units in mm) for 30 Hz frequency 
(a) DIET Healthy phantom, (b) Finite element analysis (FEA) Healthy phantom, (c) DIET 20 
mm inclusion position indicated with a black circle, (d) FEA 20 mm inclusion position 
indicated with a black circle, (e) DIET 10 mm inclusion position indicated with a black circle 





Figure 5.12: Average radial displacement distribution (all units in mm) for 32 Hz frequency 
(a) DIET Healthy phantom, (b) Finite element analysis (FEA) Healthy phantom, (c) DIET 20 
mm inclusion position indicated with a black circle, (d) FEA 20 mm inclusion position 
indicated with a black circle, (e) DIET 10 mm inclusion position indicated with a black circle 
and (f) FEA 10 mm inclusion position indicated with a black circle 
 
 
5.3 Accuracy of dynamic trajectory using cross correlation coefficient 
The cross correlation coefficient for all 4200 surface points over all 10 frames at each 
frequency were calculated to analyse discrepancies in the trajectory of the dynamic response 
between FEA and DIET experimental results. It measures the degree to which both data sets 
vary in the same direction, or oppositely. It is thus a strong validation for DIET, which uses 
dynamic response over all frames as a diagnostic.  
 
The resulting cumulative distribution functions for each phantom at 28 Hz, 30 Hz and 32 Hz 
of these values is shown in Figures 5.13-5.15. Tables 5.1-5.3 summarize these results. Over 
all frequencies more than 90% of points have a cross correlation coefficient         




existence of many local effects not taken into account by the more homogenous finite 
element modelling. Finally, 99-100 % of values have > 0.8 which is still a very good 
correlation result. 
 
Figure 5.13: Empirical distribution (F(x)) of cross correlation coefficient (x) of all points at 
28 Hz for: a) Healthy Phantom; b) 10 mm inclusion; and c) 20 mm inclusion. The solid lines 
show the x = 0.90 value and quantify its likelihood. The dashed line shows the location for    







Figure 5.14: Empirical distribution (F(x)) of cross correlation coefficient (x) of all points at 
30 Hz for: a) Healthy Phantom; b) 10 mm inclusion; and c) 20 mm inclusion. The solid lines 
show the x = 0.90 value and quantify its likelihood. The dashed line shows the location for    






Figure 5.15: Empirical distribution (F(x)) of cross correlation coefficient (x) of all points at 
32 Hz for: a) Healthy Phantom; b) 10 mm inclusion; and c) 20 mm inclusion. The solid lines 
show the x = 0.90 value and quantify its likelihood. The dashed line shows the location for    
= 0.80 with ~99-100 % of the values having     0.80 
 
Table 5.1: Summary of Cross Correlation coefficients at 28 Hz  
Range of cross 
correlation 
coefficient 
Number of data points 
 Healthy 10 mm Inclusion 20 mm Inclusion 
0.9-1.0 3939/4200 (93.78%) 3049/4200 (72.59%) 2874/4200 (68.42%) 
0.8-0.9 249/4200 (5.92%) 1099/4200 (26.16%) 1269/4200 (30.21%) 
0.7-0.8 11/4200 (0.26%) 49/4200 (1.16%) 50/4200 (1.19%) 





Table 5.2: Summary of Cross Correlation coefficients at 30 Hz 
Range of cross 
correlation 
coefficient 
Number of data points 
 Healthy 10 mm Inclusion 20 mm Inclusion 
0.9-1.0 4055/4200 (96.54%) 3950/4200 (94.04%) 3619/4200 (86.16%) 
0.8-0.9 124/4200 (2.95%) 242/4200 (5.76%) 579/4200 (13.78%) 
0.7-0.8 21/4200 (0.50%) 7/4200 (0.16%) 2/4200 (0.04%) 
<0.7 0/4200 (0.00%) 1/4200 (0.02%) 0/4200 (0.00%) 
 
 
Table 5.3: Summary of Cross Correlation coefficients at 32 Hz 
Range of cross 
correlation 
coefficient 
Number of data points 
 Healthy 10 mm Inclusion 20 mm Inclusion 
0.9-1.0 4152/4200 (98.85%) 4045/4200 (96.30%) 3964/4200 (94.38%) 
0.8-0.9 46/4200 (1.09%) 155/4200 (3.69%) 234/4200 (5.57%) 
0.7-0.8 2/4200 (0.04%) 0/4200 (0.00%) 2/4200 (0.04%) 







The overall results in Figures 5.1-5.9 matched well. For the healthy phantom in Figures 5.1-
5.3 for frequency 28 Hz, 30 Hz and 32 Hz the displacement is expected to be evenly 
distributed due to its homogenous, symmetric fabrication. However, the displacement 
distribution from frame 2 to 3 in Figure 5.1 and from frame 3 to 4 in Figure 5.2 near the 
actuator are uneven, indicated by a black circle, leading to some loss of symmetry which may 
be due to off-center application of the 2N preload, or an inhomogeneous part of the phantom. 
This effect is also seen in Figures 5.4-5.9 in other frames for the 10 mm and 20 mm inclusion 
phantoms. These local differences are evident but otherwise, the overall match between DIET 
experiments and the FE model is qualitatively good. 
 
Figures 5.10-5.12 result provides further strong qualitative validation, but does not provide a 
specific numerical level for that correlation in matching values. Nor does it provide the 
necessary trend validation showing how the dynamic response that provides these values in 
Figures 5.1-5.9 and 5.10-5.12 are, or are not, similar. This last criterion requires the cross 
correlation coefficient value, and quantifies this level of validation explicitly as assessed by 
the frame to frame trend over the entire dynamic response. 
 
The cross correlation values in Figures 5.13-5.15 and Tables 5.1-5.3 are very high. Thus, 
while small errors in material properties may cause motion magnitude differences, as seen in 
Figures 5.1-5.9, the overall dynamic response is well matched. Hence, the trajectory across 
all k = 1…10 frames appears valid, which is the key aspect in DIET diagnostics, as the 
changes to this trajectory, in the presence of stiffer inclusions, is the focal point of the 
diagnostic approach. Hence, trajectory matching over all k = 1…10 frames is critical to 




given qualitatively good frame to frame magnitude matches. Especially, when considering 
variation in tissue density and stiffness can vary very significantly across women. 
 
One primary reason of lower values between 0.8-0.9 of the cross correlation coefficient is 
DIET measurement error. Each node on the surface of the breast follows a loop of 10 points, 
and there is measurement error on every single point, which can degrade perfect correlation. 
This error is in the order of 6%, down to 2-3 μm [188], and is thus larger for nodes with 
smaller motions, such as near the chest wall. In addition, the small local discrepancies in 
Figures 5.1-5.9 will yield much lower cross correlation coefficients. 
 
In addition, the experimental input sine wave is not always perfect, whereas the FE model 
input is ideal. This issue is another possible cause for the differences seen, particularly in 
Figures 5.1-5.9. Overall, these limitations are mitigated by the strong results in Figures 5.13-
5.15, which are central to demonstrating the utility of these models to replace experimental 
phantom tests in surface motion analysis and diagnostics metric development.  
 
Overall, these results demonstrate the FEA modelling approach presented can predict surface 
motion of these silicone breast phantoms to high correlation levels (over 0.90). The results in 
Figures 5.13-5.15 show it captures the changes necessary for developing diagnostic metrics 
and analyses from the FE model independent of exact tissue stiffness, which varies between 
women. The homogenous healthy phantom shows slightly better validation than the 10 mm 
and 20 mm inclusion cases at 28 Hz, 30 Hz and 32 Hz. However, certain assumptions 
regarding the finite element modelling, such as excluding skin, gravity and body mass may 
also have produced some differences particularly in magnitude of response, as seen in the 




A further limitation is the cancerous lesions mimicked within the FE modelled breast 
phantoms were connected to healthy tissues without the ability to slide past one another, a 
perfect connection with perfect, as modelled stress-strain transfer. Real lesions are strongly 
connected to tissues but, as in the phantoms modelled here, it is important to note that there 
may be some form of spring or other relationship defining how they connect and transfer 
stress and strain due to the way they are manufactured.  
 
In this case, the results were strong enough to ensure a good model match. However, going 
forward, it will be necessary to investigate the effect on displacement from imposing slip 
boundary conditions between cancerous tissues and healthy tissues. Such improvements 
could improve the modeled phantoms, as well as better reflect the actual physiology, as well. 
 
Another limitation is the Neo-Hookean hyper-elastic model chosen to simulate these breast 
phantom tissues in this study. The phantoms are relatively homogeneous supporting this 
assumption. However, real breasts will be more heterogeneous even across similar tissue 
types. Thus, going forward, it would be interesting to assess more detailed mechanics models, 
such as the Ogden and Mooney Rivlin models, to investigate their effect on surface 
displacement distributions, and if they can provide a more detailed model in those cases.   
 
A final limitation of this study is the lack of comparison to other studies. The only research in 
the area of DIET in general has been by the authors group, as it is still a unique approach. In 
particular, while elastography is a growing field in general, primarily via ultrasound and MRI 
data [172, 173, 180], this mechanical approach in DIET is unique at this time to the best of 
the authors‟ knowledge. In particular, the phantoms normally used for development and 




normally defined by their properties in relation to these modalities and input waves (acoustic 
and radio frequency electromagnetic). In this case, the phantoms are for DIET defined by 
their mechanical properties relative to breast tissues [184, 185], which is distinctly unique 
from the properties normally considered. Thus, the study presented lacks prior comparisons 




The results show an efficient FE breast model for silicone phantoms covering healthy and 
inclusion cases that provides predictions of the frame to frame displacement distribution 
under dynamic loading conditions based on high correlation values with only small 
differences in magnitude. These differences are due to a range of un-modelled effects. Any 
inconsistency between finite element model and DIET experimental data can be improved by 
reducing experimental errors, as well as improving the material properties used in the model. 
However, the modelling approach presented can be generalized to other similar cases, and for 
these biomedical tissue phantoms it captures all the key dynamics necessary to use them in 
place of experimental phantom tests in the analysis of surface motions based on the 
correlation results presented comparing experimental and model results. Thus, it creates a 






Chapter 6: Laser Doppler vibrometer validation of an 




In this chapter, breast-shaped fabricated phantoms from Chapter 3 are used with laser 
Doppler vibrometry to validate the optical flow (OF) motion measuring algorithm used in 




Laser Doppler vibrometers (LDVs) are devices used to measure the instantaneous velocity or 
displacement of vibrating surfaces. A displacement measurement can provide useful 
information for medical applications, and can be particularly useful for DIET. The laser 
vibrometer provides a remote, non-contact measurement. Laser measurement is considered 
one of the most promising three-dimensional measurement methods, due to it is high 
resolution and non-destructive non-contact modality. Biomedical applications of this 
measurement, such as 3D scanning, include anatomical reconstruction [271], orthodontic 
treatment planning [272], cranial deformation research [273], cartilage morphology studies 
[274], anthropometric data collection [275]. 
 
There are typically three types of laser vibrometer, single point laser vibrometers, scanning 
laser, and 3-dimensional scanning lasers. Single point laser vibrometers measure the velocity 
or displacement of a single point on an object surface. Scanning systems can measure 




measure 3D vibration of a planar or non-planar surface [276]. In this chapter, a single point 
laser Doppler vibrometer used for horizontal measurements. 
 
There are also several limitations to laser vibrometry. Line of sight requirements make 
measurements demanding, especially on complicated 3D geometries, such as a breast. 
Measurement quality also depends upon surface quality, particularly if a laser beam strikes an 
optically rough surface, such as skin, where the laser wavelength (633 nm for the red HeNe 
laser) is on the scale of surface roughness. Reflective tape is thus a commonly used surface 
treatment in laser vibrometer measurements to maximise the return light intensity [277].  
 
Overall, it is not a suitable replacement for OF, but would be useful to validate measured 
motions obtained from OF. In this chapter, a single point laser Doppler vibrometer system 
made by Polytech (North America, USA) is used to validate horizontal out-of-plane 
measurements calculated using OF for a series of breast-shaped phantoms. 
 
 
6.2 Materials and methods 
6.2.1 Sample preparation 
Retro-reflective tape is a commonly used surface treatment in laser vibrometer measurements 
to maximize the return light intensity. Because the silicone surface is oily and tape absorbs 
oil, to ensure that the reflective surface are free of dirt and oil which can reduce the effective 
reflectance of the surface therefore, different sizes of glass beads and ARDROX were used to 
test the laser intensity and received signal. Glass beads with mesh size of 100 um with 
reflective index ND>1.97 were found to maximise the return light intensity. These materials 





Figure 6.1: (a) Mixing silicone pigment with silicone oil; (b) Removing bubbles from 
silicone; (c) Pouring exact amount of silicone liquid; (d) Samples fabricated under 50 
o
C; (d) 
Reflective glass beads size varies from 500 to 100 um and ARDROX 
 
Three silicone based homogenous breast shaped phantoms were created as per Chapter 3. 
One was homogenous and „healthy‟, and the remaining two had a 10 mm and a 20 mm 
inclusions to simulate tumors. Phantom dimensions and fabrication procedures were followed 
from published reports [185] and Chapter 3. There are these three test validation cases. 
 
6.2.2 Experimental set-up 
A schematic of the measurement hardware for the experiment is shown in Figures 6.2 - 6.4. A 
Polytech (North America, USA) laser Doppler vibrometer system was used. The laser 




head using a low-power (class 2) Helium Neon laser. The vibrometer controller delivers 
signals and power to the sensor head, and processes the return signals. Interference of the 
measurement and reference beams occurs in the sensor head, and results in a fringe pattern 
from which frequency and phase difference signals are determined. These signals are sent to 
the controller where they are decoded. 
 
With a range of actual DIET screening manufacture boundaries, a new prototype DIET was 
built to simulate DIET as shown in Figures 6.3 and 6.4. In prototype DIET a D.C motor 9700 
RPM is attached. When the specified voltage is supplied to a motor, it rotates the output shaft 
at some speed. The maximum 12 volts can be applied to get 161 Hz with no load. In this 
experiment only 16 Hz to 40 Hz were required as input frequency.  
 
In actual DIET screening experiments, a two Newton (2N) preload is applied, which ensures 
full contact between the phantom and the actuator and does not squash the phantom. In 
prototype DIET 5 shims of 1 mm thick were placed to apply preload as 2N. This 5 mm 
displacement preload was selected from Chapter 4 finite element modelling. Steady state 
mechanical, sinusoidal input oscillations of 16Hz, 24Hz, 32Hz, and 40Hz of low amplitude, 1 
mm peak to peak, is applied to the phantom tip, while hanging pendulous [28, 30, 185]. 
Horizontal out of plane displacements of the phantom surface were measured using laser 
Doppler vibrometer. The experiments were carried out on top of a vibration isolation table to 
avoid unnecessary surrounding vibration. The summary of measured points on the phantom 





Each phantom was equally divided into 4 quadrants and 9 surface points were recorded on 
each section. Therefore, 36 surface points were recorded for each phantom. These 36 points 
are also shown in Figure 6.5. 
 
To ensure reliability, each phantom was tested twice and the average of the resulting peak 
magnitude displacement were calculated for each phantom and point. As the surface points 
were marked on each phantom, the laser beam was directed on the same position and verified 
by eye. Comparisons of surface points serves to validate the accuracy of the DIET surface 
point OF measurement algorithm [188]. 
 
 






Figure 6.3: Prototype DIET 
 
 






Figure 6.5: (a) Top view of phantom - summary of marked surface points on the breast 
shaped healthy, with a 20 mm and a 10 mm inclusions phantom for displacement 
measurement; (b) laser Doppler vibrometer equipment. 
 
6.2.3 Optical flow validation 
In this section, positive peak magnitudes of horizontal displacement from the sinusoidal 
response captured by OF are compared to those assessed by laser doppler. Horizontal 
displacements of multiple surface points on the breast shaped phantoms are measured from 
single point laser Doppler vibrometer. These peak horizontal displacement values are 
compared to validate the DIET OF derived experimental data. The position of surface points 
on the phantom surface for the three phantom cases tested are also explained in Figure 4.1 in 
Chapter 4, as well as in Figure 6.5. 
 
 
6.3 Results and discussion 
6.3.1 Validation of DIET OF algorithm 
Figure 6.6 shows LDV measured displacement at 16 Hz input frequency for a single section, 
which includes N=9 surface points on the healthy, no inclusion phantom. Figures 6.7 and 6.8 




Hz, and 40 Hz on the 3 breast shaped phantoms for the LDV and DIET experimental data, 
respectively.    
    
 
Figure 6.6: Laser Doppler vibrometer data for each quadrant with excitation amplitude of 
1mm peak to peak on a healthy phantom surface at 16 Hz sinusoidal excitation, (a) 9 points 
of section 1; (b) 9 points of section 2; (c) 9 points of section 3; (d) 9 points of section 4. 
 
The healthy breast phantom is homogenous and the peak positive horizontal displacement 
measured from the homogenous healthy phantom are assumed to be the same on all sides. In 
Figure 6.7, it can be noticed that the positive peak of horizontal displacement of this healthy 
phantom for each frequency is almost equal in all sides, as expected. Any fluctuation in 
points may be due to misalignment between the phantom surface and the laser beam, as the 
direction of the laser beam is manually changed to investigate each point on the phantom 




in positioning introduces a systemic bias. It may also be due to small in-homogeneities in the 
experimental phantom. 
 
It has been well recognised that inclusions are 4-10 times stiffer than the surrounding breast 
tissues [270] as described in Chapter 3 as well. The tissue displacements are inversely 
proportional to the stiffness of the tissue. Thus, a stiffer region of tissue exhibits smaller 
displacements than a more compliant region [27, 28]. The dashed circle shows the peak value 
of horizontal displacement near the inclusions are smaller than the rest of the sides. However, 
the peak displacement magnitude of non-stiffer inclusion regions for both 10 mm and 20 mm 














Figure 6.7: Laser Doppler vibrometer data - excitation amplitudes of 1mm peak to peak on 
phantom surface (a) 16 Hz excitation; (b) 24 Hz excitation; (c) 32 Hz excitation; (d) 40 Hz 
excitation 
 
Similarly, Figure 6.8 shows the peak horizontal displacement values of DIET OF calculated 
experimental motion data for all three phantoms. It is clear the laser Doppler vibrometer data 
are less variable than DIET experimental data. This difference occurs because the laser 
sensitivity/resolution is high compared to the DIET OF reconstruction procedure. 
  
In addition, DIET OF experimental motion data measured in 3D, whereas the laser Doppler 
vibrometer data are measured in 2D. Finally, the position of the DIET OF data points is not 









The peak horizontal displacement values of the DIET OF for the healthy phantom are almost 
equal in all frequencies, which shows the phantom is homogenous and is an expected result. 
For phantoms with inclusions, the displacement near the inclusion is smaller than the 
surrounding tissues.  
 
The peak horizontal displacement values difference for the 20 mm inclusion is bigger than 
the 10 mm inclusion. Thus, the peak magnitude displacement near the 20 mm inclusion is 
much smaller than for the 10 mm inclusion phantom and region, but the difference was larger 
than seen with the laser Doppler vibrometer. 
 
Figure 6.9 compares separate DIET OF and laser doppler experimental data for each 
actuation input frequency and phantom. Table 6.1 shows the percentage calculated error 
range for all 36 surface points between laser doppler and DIET OF for all three phantom 
cases. The percentage error decreases with increasing frequency. Peak amplitude also 
decreases with the increasing of frequency. Almost all errors are less than 8 %, which is very 












Figure 6.8: DIET OF experimental data - excitation amplitudes of 1mm peak to peak on 










































































Figure 6.9: Peak amplitude of DIET and laser Doppler vibrometer experimental data (a) 16 
Hz excitation; (b) 24 Hz excitation; (c) 32 Hz excitation; (d) 40 Hz excitation 
 
Table 6.1: Summary of absolute errors between LDV and DIET OF overall input 
frequencies 
Range of absolute error in % 
Frequency Healthy 20 mm Inclusion 10 mm Inclusion 
16 Hz 0.0 - 4.6 0.0 – 7.8 0.0 – 7.8 
24 Hz 0.0 – 5.4 0.0 – 6.9 0.0 – 4.9 
32 Hz 0.0 – 1.6 0.0 – 4.1 0.0 – 1.9 
40 Hz 0.0 – 4.2 0.0 – 4.2 0.0 – 2.7 
 
Overall, these results show the DIET OF measurement can accurately capture surface motion 
of these silicone phantoms, as validated by the laser Doppler vibrometer. However, there are 
several limitations using a laser Doppler vibrometer that may play a role. One of the main 
limitations is the difficulty of realizing perfect alignment between the investigated target and 
laser beam. In addition, there is always environmental noise, but this noise is very small for 
this laser Doppler vibrometer. In all cases, the error appears very consistent with no apparent 
bias. Hence, the OF method can be conducted to provide lower error motion with resolution 
























The results of the laser Doppler validation of DIET OF indicate that the method works well. 
The overall average absolute error for 16 Hz, 24 Hz, 32 Hz, and 40 Hz are 20 μm, 50 μm, 10 
μm, and 20 μm respectively, which indicates that the OF method has good resolution. In 
addition, 90% of errors between LDV and DIET OF data are < 5 %, and this shows that 
DIET OF tracks points very well. Overall, the OF method is thus validated against a gold 
standard and its level of resolution quantified. Knowledge of both of these metrics is 







Chapter 7: Finite element modelling for different sizes 




In this chapter the same finite element (FE) modelling and data analysis procedure from 
Chapters 4 and 5 were used to model phantoms with stiffer 10 mm and 20 mm inclusions at 
different positions using input actuation frequencies of 16 Hz, 24 Hz, 32 Hz and 40 Hz. The 
goal is to create an initial test of how well phantom inclusions might represent their stiffer 




Due to the good validation of the finite element (FE) modelling of DIET experimental 
phantom data described in Chapters 4 and 5, these models and methods were used to model 
phantoms with the same inclusion sizes but at different locations. The same hyper-elastic 
properties and phantom dimensions from Chapter 3 were used in modelling. The more 
specific goal is to assess and quantify the robustness and sensitivity of potential surface 
motion diagnostics to inclusion location, particularly to depth. It is thus an initial application 
using FE models in place of extensive experimental series. 
 
 
7.2 Finite element modelling 
A total of 6 breast shaped phantoms were modelled with the same overall geometry and 
dimensions, loading, material properties and boundary conditions used in Chapter 4. Two 




different positions. Input actuation frequencies of 16 Hz, 24 Hz, 32 Hz and 40 Hz were used. 
The three inclusion locations are described in Figure 7.1. All of them can be located in an (X, 
Z) plane, Figure 7.2 shows the inclusion locations in further detail on an (X, Z) plane slice. 
For simplicity only locations A, B, and C will be used for reference. 
 
Figure 7.1: Three phantoms configurations were each modelled with two different sizes of 
inclusions at positions: (a) (X, Y, Z) = (35, 0, -13); (b) (X, Y, Z) = (12, 0, -23); and (c) (X, Y, 
Z) = (15, 10, -43) yielding 6 phantoms in total 
 
 
Figure 7.2: (X, Z) planar slice showing three locations of inclusions: Each of the 6 phantoms 
with 20 mm and 10 mm inclusions at positions (X, Z) = (35, -13) mm, (12, -23) mm, and (15, 





Similar to Chapter 4, a 3D free mesh was assembled using quadratic tetrahedral ten-node 
C3D10M (Continuum 3Dimensional 10-node Modified) elements using ABAQUS version 
6.14 (ABAQUS Inc., Johnston, Rhode Island, United States). To avoid small gaps between 
the phantom surface nodes, a mesh size of 1 mm was used in these models. There were 
approximately 69000 surface nodes on each phantom model. 
 
 
7.3 Model analysis 
The overall average radial displacement values over all   = 10 frames with   = 1…69000 
surface points are compared using Equation 4.2, repeated here: 
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 (7.1) 
Where  ,   and     are as defined in Chapter 4, Equation 4.1 
 
 
7.4 Results and discussion 
Figures 7.3-7.8 show the average radial displacement for 16 Hz, 24 Hz, 32 Hz and 40 Hz 
sinusoidal input actuation for each node on the phantom surface (   ). The 10 mm and 20 
mm inclusions are located with a black dotted circle. The average radial displacement reduces 
with increasing input actuation frequency. Thus, the maximum displacement on the color bars 
was fixed to 0.3 mm for 16 Hz and 24 Hz and 0.1 mm for 32 Hz and 40 Hz. All figures show 
larger displacements nearer to the actuator and smaller to zero displacement at the chest wall, 
as expected.  
 




Displacement at the phantom surface is inversely proportional to the inclusion stiffness and 
because inclusions have higher stiffness than healthy tissues, smaller motion can locate an 
inclusion. The 10 mm stiffer inclusion is small and inserted near to the phantom surface in 
this region,  and thus a small region is effected with smaller average radial displacement near 
the inclusion. 
 
Figure 7.3: Location A: Average radial displacement distribution (all units in mm) for a 10 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 
Hz; and (d) 40 Hz 
 
Figure 7.4 shows results for a 10 mm inclusion located 12 mm from the centre of the 
phantom at location B. It is difficult to locate the inclusion from the top view of the phantom. 
However, Figure 7.4 (c) shows the small differences in radial average displacement between 








Figure 7.4: Location B: Average radial displacement distribution (all units in mm) for a 10 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 
Hz; and (d) 40 Hz 
 
Figure 7.5 shows 10 mm inclusion case at location C, which is slightly off centre in Figure 




the smaller average radial displacements at frequencies of 16 Hz and 24 Hz. However, input 
frequencies of 32 Hz and 40 Hz show smaller average radial displacement only near to where 
the inclusion is inserted, and the rest of the phantom region reacts as healthy tissue. Thus, 
each frequency react somewhat differently in this case, but all of them locate the inclusion. 
 
Figure 7.5: Location C: Average radial displacement distribution (all units in mm) for a 10 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 
Hz; and (d) 40 Hz 
 
Figure 7.6 shows promising results for the larger 20 mm inclusion at location A. A greater 
region on the phantom surface displays the impact of the inclusion from the chest wall to the 
bottom of the phantom near the actuator. It is again located by smaller average radial 






Figure 7.6: Location A: Average radial displacement distribution (all units in mm) for a 20 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 
Hz; and (d) 40 Hz 
 
Figure 7.7 shows the results for the 20 mm inclusion at location B, 12 mm from the centre of 
the phantom. Half of the phantom surface is affected and shows smaller average radial 
displacement compared to the other side. The black thick line divides the phantom to clearly 
indicate the side affected by the inclusion, and the healthy side. In contrast, the 10 mm 
inclusion in Figure 7.4 showed a much smaller affected region. Finally, Figure 7.8 shows the 
case with the 20 mm inclusion inserted near the actuator in location C. These results and 
others indicate that the inclusion is near to the phantom surface, a greater region will be 







Figure 7.7: Location B: Average radial displacement distribution (all units in mm) for a 20 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 
Hz; and (d) 40 Hz 
 
The overall results are promising for diagnostics and show robustness to location chosen. In 
general, the larger the inclusion, the greater the area affected. Equally, the deeper the 
inclusion, the smaller the area affected. Thus, the average radial displacement varies 
throughout the phantom surface as a function of inclusion location and actuation frequency. 






Figure 7.8: Location C: Average radial displacement distribution (all units in mm) for a 20 
mm inclusion located with a dotted black circle at frequencies of: (a) 16 Hz; (b) 24 Hz; (c) 32 




The same FE modelling procedure validated in Chapter 4 and 5 was used to model new 
phantoms with 20 mm and 10 mm diameter stiff inclusions and at different positions. The 
goal was to assess the sensitivity and robustness of surface motion with inclusion position 
and actuation frequency. The results show inclusions can be identified with surface motion at 
every frequency using average radial displacement to locate stiffer inclusions. Average radial 
displacement varies with changing inclusion position. Thus, these results can help DIET 









Breast cancer is a major health issue. Globally, millions of women are diagnosed with breast 
cancer and many of them die every year globally. Early detection of breast cancer improves 
treatment effectiveness and enhances the odds of survival. The most typical breast cancer 
screening methods, include MRI and mammography. However, due to drawbacks and 
limitations around cost, discomfort, and invasiveness, there is need of better screening 
techniques. 
 
Digital imaged elasto-tomography (DIET) has been developed to overcome some of the 
limitations of current techniques. This technique enables non-invasive, low-cost screening, 
which could enable earlier detection of breast cancer. Combined with effective treatment, 
early detection is proven to reduce both mortality and the total cost of cancer screening and 
care. Thus, DIET offers a significant potential improvement in the ability to screen for cancer 
and improve outcomes.  
 
The research presented in this thesis addresses three major significant issues hindering DIET 
development. These issues include the lack of a rapid ability to develop the system with an 
over reliance on clinical testing and technology improvement, which is slow and can be 
skewed by outlying response. Equally, a clinical testing approach does not allow re-testing 
easily when systems are improved, so that improvements cannot be well-quantified. Finally, 
the current prototypes measure surface motions with advanced algorithms. However, their 




which limits the ability to determine if surface motion based diagnostics have the resolution 
to detect stiffer inclusions within the error induced by measurement error of surface motions. 
 
Thus, this thesis directly examines: a) the development of more realistic tissue mimicking 
breast phantoms using silicone materials; b) validation and quantification of the error of the 
surface motion measurements and algorithms; and c) finite element modelling of silicone 
phantoms, which would provide a faster approach to development, as finite element methods 
could provide “data” far faster and then be validated in limited phantom experiments, all 
before clinical validation and testing.  
 
The aim for the first issue was to find the most suitable commonly available material to 
mimic breast tissue, for use in DIET development. The linear and nonlinear mechanical 
properties of agar, gelatin, and silicone materials are measured and compared with real breast 
tissue values from the literature to develop a best formulation that offered repeatability and 
good representation of the tissue material properties. Two widely recognised measurement 
procedures are used. Quasi-static uniaxial compression was performed under a strain rate of 
0.5 mm/min up to 15% strain with preloads of 0.05 N, 0.1 N, and 0.2 N, was used to measure 
the elastic moduli. Dynamic testing over a frequency range of 0.1-50 Hz for agar and 0.1-100 
Hz for gelatin and silicone with the same preload was used to measure the storage moduli. 
Elastic and storage moduli were (5-81 kPa, 17-85 kPa, 5-112 kPa) and (3-128 kPa, 10-109 
kPa, 5-73 kPa) for agar, gelatine, and silicone, respectively at the three preloads. Finally, 
breast shaped mimicking silicone phantoms were fabricated for in vitro trials of a DIET 
breast cancer screening system assessing changes in mechanical properties. These results thus 
enable easily fabricated and repeatable testable tissue mimicking breast phantoms for 




Finite element modelling and laser Doppler vibrometry are presented to quantify errors and 
validate current optical flow algorithm, based on surface displacements of the breast phantom 
using a laser-based gold standard measurement, which is important, as surface motion is the 
key diagnostic metric in the DIET concept. Finite element modelling results showed good to 
strong correlation ranging from 0.7 to 1.0 in all cases with over 90% having a value over 0.9. 
Magnitudes for each frame of the dynamic response also matched well, indicating the 
material properties and geometry were accurate enough to provide this level of correlation. 
The results from the optical flow motion algorithm used with DIET and a laser Doppler 
vibrometer show the optical flow algorithm captures surface motion of breast shaped silicone 
phantoms with good accuracy. Thus, measurement error was quantified and found to be on 
the order of 10um or less. This value can thus be used to quantify the range of error of any 
motion-based diagnostics developed. The optical flow algorithm is thus suitable and robust 
enough for use in clinical breast screening. 
 
These first two outcomes justified the development of FE models to generate data for 
development, prior to phantom testing, saving further time and experimental effort. Results 
showed good correlation throughout the dynamic response cycle between experimental and 
FE model results. In particular, the results of further FE modelling also show inclusions can 
be localised and detected, and these results can help in development of DIET screening 
diagnostics. Thus, the results justify the use of FE model data in lieu of experimental 
phantom data for development. The overall modelling approach was also relatively simple, 





In summary, all these major significant issues which impeding DIET development were 
successfully addressed. All of these requirement enable faster and more robust development 































9.1 Complex breast phantom 
Real human breast tissue is complex and contains different kind of tissues such as fatty, 
glandular and fibrous tissues. Current fabricated phantoms have only skin, adipose and 
cancerous tissues. Fabricating different sizes of homogenous and heterogeneous breast 
phantoms by adding glandular and fibrous tissues would benefit future research endeavours 
in the development of DIET screening methods. Considering and investigating mechanical 
properties of different types of silicone materials for glandular and fibrous tissues which 
should match real breast tissues would help in making heterogeneous breast phantom. 
 
There were only one material considered for cancerous tissues. Investigation the mechanical 
properties of benign and malignant tumors and creating phantoms that resemble both benign 
and malignant tumors would be another recommendation. 
 
 
9.2 Finite element modelling of complex breast phantom  
In DIET experimental data, two preload force applied on breast phantoms, a 2N and a 4N 
preload. In this thesis, only 2N preload data of DIET and finite element methods were 
validated. In future work the validation process can also be performed for 4N preload. 
 
Same procedure can be follow to validate DIET experimental results and finite element 








9.3 Other measurement methods 
Using other measurement methods to analyse surface motion of the breast phantoms would 
be recommended. In this thesis single point laser Doppler vibrometer was used to measured 
horizontal displacement on the phantom surface, in future 3D laser scanning can be used to 
measure 3D displacements at phantom surface.  
 
Edge detection technique is another method to extract features from an image. Because edges 
provide connectivity information between nodes, and curved lines. The majority of common 
edge detection techniques detect edges by calculating the gradient or first partial derivatives 
in the horizontal and vertical directions of the image. Edge detection algorithms  which  
utilize  first  derivative  operators  include  the  Roberts,  Prewitt, Sobel, Frei-Chen, and 
Canny algorithms. DIET captures 50 images from different camera angles at different phase. 
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